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ABSTRACT 
 
Chemopreventive Potential of Sorghum with Different Phenolic Profiles.  
(December 2009) 
Liyi Yang, B.E., Nanjing Agricultural University, China 
Chair of Advisory Committee: Dr. Joseph M. Awika 
 
Epidemiological evidence has correlated consumption of sorghum with reduced 
incidences of gastrointestinal (GI) tract cancer, especially esophageal cancer. There is 
little evidence on how phenols of sorghum may affect chemoprevention. Seventeen 
sorghum varieties were screened for phenolic profiles and antioxidant capacity. The 
ability of crude sorghum extracts to induce NAD(P)H:quinone oxidoreductase (QR, a 
phase II protective enzyme), and inhibit proliferation of colon (HT-29) and esophageal 
(OE33) carcinoma cells using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) and PicoGreen assays, were determined in vitro. 3-
Deoxyanthocyanidins, apigeninidin, luteolinidin and their methoxylated derivatives were 
also investigated for antioxidant capacity, QR inducing and antiproliferative potential. 
Tannin sorghum generally showed higher antioxidant capacity than non-tannin 
sorghum varieties. Sorghum varieties containing extractable condensed tannins did not 
show any significant QR inducing potential; on the other hand, non-tannin sorghums 
increased QR activity by 1.5-2.7 times; black sorghum (Tx430) was most potent 
(doubled QR activity at 25 μg/mL, 2.7-fold increase at 100 μg/mL). All sorghum 
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extracts showed relatively strong antiproliferation activity with IC50s (the concentration 
needed to inhibit cancer cell growth by 50%) of 49.7-883 μg/mL. Tannin-containing 
sorghums had stronger cancer cell proliferation inhibitory potential (IC50s 49.7-131 
μg/mL) than non-tannin sorghums (IC50s 141-883 μg/mL). Total phenol content and 
antioxidant capacity of crude sorghum extracts positively correlated with their 
antiproliferative potential (r2 0.71-0.97).  
 Among tested 3-deoxyanthocyanidins, methoxylation on A-ring improved QR 
inducing potency. 5,7-Dimethoxyluteolinidin had the greatest QR inducing potency (4.3-
fold at 100 μM). Methoxylation also improved their antiproliferation potential; the IC50s 
trend was di-methoxylated (8.3-105 μM) > mono-methoxylated (40.1-192 μM) > 
apigeninidin and luteolinidin (81.5-284 μM). 
 This study provides information for how phenolic compositions of sorghum and 
3-deoxyanthocyanidin structure affect their capacity to induce QR activity and inhibit GI 
tract cancer cell proliferation. The information is useful to promote the utilization of 
sorghum in functional foods, beverages, dietary supplements, and other health-related 
industries. Further study will focus on, fractioned and isolated sorghum phenols, the 
effect of food processing on their chemopreventive potential, as well as cellular 
mechanisms involved. 
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CHAPTER I 
INTRODUCTION 
 
Cancer is the second leading cause of death in the US and 1.4 million new cases 
of cancer were expected to be diagnosed in 2008 (1). Eighty-nine billion dollars was 
spent on direct cancer-related medical care in 2007 in the US (2). Most cancer incidence 
(90-95%) is related to diet, lifestyle and environment (3). Hence effective use of dietary 
components to reduce the risk of developing cancer is desirable.  
Diets rich in fruits and vegetables reduce the risk of cancer in various sites (4-7). 
The plausible mechanism is not clear but is possibly related to intake of fiber, vitamins, 
minerals and dietary antioxidants (8). Consumption of whole grains is also associated 
with lower incidence of cancer, especially digestive system cancers. Complex 
carbohydrates, vitamins, minerals and phenolic compounds in whole grain are partly 
responsible (9-13).  
Epidemiological studies have shown that a staple diet of sorghum correlates with 
low incidence of esophageal cancer in areas where this type of cancer is endemic (14-
18). However, how sorghum contributes to this chemoprevention and which components 
of sorghum are responsible is unclear. Sorghum has a unique profile of polyphenols, 
such as condensed tannins, flavones and 3-deoxyanthocyanins, not commonly found 
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in wheat, corn, rice, and other cereals. These polyphenols may be responsible for the 
chemopreventive properties of sorghum. For example, 3-deoxyanthocyanins were 
recently reported as stronger cancer cell proliferation inhibitors than their anthocyanin 
analogs (19). The unique compounds in sorghum should be evaluated for their 
chemoprevention potential. 
Carcinogenesis generally involves three main steps: initiation, promotion and 
progression (20). Chemopreventive agents could target any of these three steps, such as 
blocking activation of carcinogens, activating transcription factors that regulate the 
expression of protective enzymes, and suppressing cancer promotion and/or progression 
(21). Thus dietary compounds that have such properties may be important in 
chemoprevention. For example, dietary antioxidants could prevent or block the insults 
from carcinogens and oxidative stresses in vitro. Dietary compounds that induce phase II 
detoxifying enzymes could directly protect normal cells by detoxifying potential 
carcinogens. Additionally, the capacity of food components to directly inhibit cancer cell 
proliferation may indicate their ability to suppress preformed cancer promotion and 
progression.  
This study aims to evaluate the primary chemopreventive effects of different 
types of sorghums and how their phenol profile affects this potential via in vitro cell 
culture studies. This will allow for selection of sorghum varieties with the best potential 
for chemoprevention for further studies of the molecular mechanisms involved, as well 
as effect of food processing conditions on activity and bioavailability of the active 
components of sorghum.  
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The objectives of this study were to: 
1. Compare the capacity of different varieties of sorghum to induce phase II 
enzyme activity in vitro; 
2. Compare the capacity of different varieties of sorghum to inhibit colon and 
esophageal cancer cell proliferation in vitro; 
3. Determine the effect of sorghum 3-deoxyanthocyanidin structure on phase II 
enzyme activity and GIT cancer cell growth inhibition in vitro. 
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CHAPTER II 
LITERATURE REVIEW 
 
The Prevalence of Cancer 
North America has the highest prevalence of cancer, with 1.5% of the population 
(over 3.2 million individuals) affected during the previous 5 years (22). Western Europe, 
Australia and New Zealand have similar percentages of affected population (1.2% and 
1.1%, respectively), while Japan and Eastern Europe have 1.0% and 0.7%, respectively, 
followed by Latin America and the Caribbean (0.4%), and other regions (0.2%) (22). 
Developed countries generally have similar prevalence in men and women; while in 
developing countries, the prevalence in men is 25% greater than in women. This reflects 
a preponderance of cancer sites with poor survival in males, such as liver, esophagus and 
stomach in developing countries (22). Overall, in 2006, there were 10.9 million new 
cases, 6.7 million deaths, and 24.6 million persons living with cancer in the world. The 
most common causes of cancer deaths worldwide are lung cancer (1.18 million deaths in 
2006), stomach cancer (700,000), and liver cancer (598,000) (23).  
In the US, cancer is the second leading cause of death (after cardiovascular 
disease) (1). It is a growing burden on public health: approximately one in two men and 
one in three women in the US will develop cancer during their lifetime. Nearly 294,120 
men and 271,530 women will die of cancer in the US in 2008 (1) and 1.44 million new 
cases of cancer will be diagnosed in 2008 (1).  
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On a worldwide basis, gastrointestinal tract (GIT) cancers account for 
approximately 20% of all cancers (24) and are a major cause of death in cancer patients 
(25). The incidence of certain gastrointestinal cancers, such as esophageal 
adenocarcinoma, liver and intrahepatic bile duct cancer, increases yearly (24). In 
general, rates of incidence of colorectal cancer are increasing rapidly in countries where 
overall risk was formerly low (especially in Japan, but also elsewhere in Asia), while in 
high risk countries, trends are either gradually increasing, stabilizing (North and West 
Europe), or declining with time (North America) (26). Among US men and women 
colorectal cancer is the most prevalent gastrointestinal tract cancer, accounting for 8-9% 
of total cancer deaths. Pancreatic, liver and intrahepatic bile duct cancer, and esophageal 
cancer accounted for about 6%, 4%, and 4% of total cancer deaths, respectively (1). 
While the incidence of colorectal cancer has decreased since the last decade, the 
incidence of esophageal, and liver and intrahepatic bile duct cancer is still increasing (1). 
Moreover, while colorectal cancer and liver and intrahepatic bile duct cancer similarly 
affect males and females, esophageal cancer mainly affects males. African Americans 
are at higher risk of GIT cancer than any other ethnic groups (1). 
The cost of cancer is one of the most important contributors of health care 
expenditures in the US. In 2007, $219 billion was spent on overall annual costs of 
cancer, with $89 billion direct medical care; $18 and $ 112 billion on costs of lost 
productivity due to illness and premature death, respectively (2). Since direct medical 
treatments, for example surgery, chemo- and radiation therapy or the combination of 
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single treatments, for cancer are hardly affordable for cancer patients, effective ways to 
prevent cancer or at least, to reduce the risk of cancer are needed. 
 
Causes of Cancer 
Cancer is a group of diseases involving cells that have defects in regulatory 
circuits, which governs normal cell proliferation and homeostasis. More than 100 
distinct types of cancer and subtype tumors are found in specific organs (27). Cancer 
cells have six common characteristics: self-sufficiency in growth signals, insensitivity to 
growth-inhibitory (antigrowth) signals, evasion of programmed cell death (apoptosis), 
limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis. 
Due to the malignant growth, cancer cells form a microenvironment to suffice their own 
growth needs and nutrient supply, which impairs the normal metabolism of the specific 
tissue where the tumor locates (27). 
Carcinogenesis is a multistep and complex process. In an oversimplified way, 
carcinogenesis is divided into initiation, promotion and progression. Initiation is the 
damage of genetic materials: DNA or RNA, which leads to unregulated cell growth. This 
step is rapid, reversible and affected by both intracellular (inherited genes, oxidative 
stress, inflammation, hormones) and extracellular (environmental including exposure to 
carcinogens, diet and lifestyle) factors. A single malignant cell reproduces itself to form 
more malignant cells in the process called promotion. This process is reversible and 
slow, sometimes taking up to 10 years (20). Finally, in the process of progression, 
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preneoplastic cells undergo neoplastic transformation, which forms a tumor with 
invasive and metastasis potential (20). 
Leading causes of cancer in general include smoking, alcohol abuse, physical 
inactivity, malnutrition, chronic infection, over-exposure to sunlight, and exposure to 
occupational or environmental carcinogens (28). Causes of gastrointestinal tract cancer 
are tightly associated with dietary components, long-term/persistent inflammation in the 
gut and environmental risk factors, which possibly lead to oxidative damage of the 
epithelial cells in the gastrointestinal tract (25).  
Smoking and alcohol abuse account for 75% of oral cancer occurrence in USA 
men. They are the two most important risk factors for oral cancer in developed countries 
(29). Alcohol consumption has been identified as a risk factor for esophagus, gastric 
cancer and colorectal cancer (30). Increased consumption of red and processed meats 
initiate oxidative damage to normal cells, activate carcinogenic compounds, or increase 
risk of cancer in the distal portion of the large intestine (31-33).  
Increased incidence of cancer in the gastrointestinal tract has been associated 
with exposure to high fat diet induced bile acids (34). The primary bile acids are 
synthesized from cholesterol in the liver, and mainly contain cholic and 
chenodeoxycholic acid (35). Deoxycholate and other hydrophobic bile acids, which are 
induced by high fat diets, generate reactive oxygen/nitrogen species (ROS/RNS) (36). 
ROS/RNS increase the oxidative stress in vivo, which causes damage to DNA and 
eventually DNA mutation (37). 
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Major chronic inflammation of the GI tract is linked to Helicobacter pylori (H. 
pylori) infection, and/or inflammatory diseases such as celiac disease, inflammatory 
bowel disease, chronic pancreatitis, primary sclerosing cholangitis, ulcerative colitis, and 
Crohn’s disease (25). Infection of viruses (mainly hepatitis B and C viruses, some 
Epstein–Barr virus and the oncogenic JC virus) also may cause chronic inflammation 
(38). Though it is still not clear how and why chronic inflammation triggers 
carcinogenesis, it has been proposed that ROS generated from inflamed epithelia causes 
oxidative damage to DNA (39). Normally, the gut epithelia are uniquely structured to 
manage interaction with a wide range of stimuli. However, repeated and/or over 
stimulation by diet and from the gut environment leads to malfunctioned responses of 
gut epithelia. Chronic inflammation begins with a trigger (dietary or environmental) 
acting on the epithelium to invoke an inflammatory response. This results in the 
activation of a number of different inflammatory cells and the generation of oxidative 
stress. Then the existing inflammation may lead to genetic and/or epigenetic alterations. 
Though repair and regeneration could help on a limited basis at early stages, over a 
longer term, the damage to DNA may result in cellular dysplasia, which finally leads to 
carcinogenesis (25). 
In the “cancer belt” extending from Northeastern China through Central Asia into 
Northern Iran and Eastern Turkey (40) where upper gastrointestinal cancers are endemic, 
poor socioeconomical conditions, barren lands, heavy metals, and soil contaminated by 
industrial toxins are major environmental risk factors for these specific cancers (41). 
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High prevalence of gastrointestinal cancers has been observed in areas where heavy 
metals and radioactive elements are ubiquitous (42, 43). 
 
Principles of Chemoprevention 
The concept of chemoprevetion entails protective actions, including retarding, 
blocking or even reversing carcinogenesis (44). The mechanisms of cancer prevention 
target any of the six physiological changes required for development of a tumor: self-
sufficiency in growth signals, insensitivity to growth-inhibitory (antigrowth) signals, 
evasion of programmed cell death (apoptosis), limitless replicative potential, sustained 
angiogenesis, and tissue invasion and metastasis (27). Wattenberg (21) proposed that 
cancer chemopreventive compounds could be divided into two basic categories, cancer 
initiation blockers and cancer promotion suppressors.  
Blocking the insult that causes damage to DNA is a major approach to preventing 
cancer initiation. Cancer initiation blockers can prevent the formation of carcinogens 
from precursor substances (21). The blockers, which are mainly antioxidants, can 
scavenge reactive ROS/RNS species or environmental carcinogens, which in turn, 
prevent potential damage from free radicals to cells (45). The cancer initiation blockers 
can also stimulate molecular pathways, such as Nrf2 (nuclear factor-erythroid 2p45 (NF-
E2)-related factor 2) to activate the production of protective phase II enzymes, such as 
acetyltransferases, glutathione-S-transferases (GSTs), UDP-glucuronyltransferases, 
NAD(P)H:quinone oxidoreductase and sulphotransferases (45). The phase II enzyme 
 10
induction system is responsible for the removal of a diverse array of electrophilic and 
oxidative toxicants.  
Phase II enzymes, which catalyze conjugation reactions producing molecules that 
can be excreted in bile or urine, can detoxify xenobiotic chemicals, including 
carcinogens (20). Dietary antioxidants perform their protective effects not only by 
scavenging ROS, but also by inducing de novo expression of genes that encode 
detoxifying/defensive proteins, including phase II enzymes (44). These xenobiotics-
activated stress response genes contain a common cis-element, known as antioxidant 
response elements (AREs). Basic leucine zipper (bZIP) transcription factors — including 
NRF (NF-E2 related factor)— bind to these ARE sequences and modulate expression of 
stress-response genes. NRF2-KEAP1 (Kelch-like ECH-associated protein 1, a negative 
regulator of NRF2) complex pathway is the one that most commonly responds to dietary 
phytochemical stimulation (46). 
The cancer promotion suppressors can activate cellular parthways to over express 
signaling molecules to induce apoptosis in abnormal cells. They can repair the damaged 
genetic materials to terminate the malignant cell growth (45). Among the intracellular 
signaling pathways related to regulation of cell proliferation and differentiation, 
mitogen-activated protein kinases (MAPKs), which belongs to the family of proline-
directed serine/threonine kinases, is one of the central cellular signaling systems 
maintaining in vivo homeostasis (47).  
Dietary phytochemicals targeting different signaling compounds in MAPKs, can 
activate or silence part of the signaling system; hence they can prevent abnormal cell 
 11
proliferation. Dietary phytochemicals can also target other cell-signaling kinases such as 
protein kinase C (PKC) and phosphatidyinositol-3-kinase (PI3K) (48). These upstream 
kinases activate a distinct set of transcription factors, including nuclear factor κB (NF-
κB) and activator protein 1 (AP1) (48). Aberrant activation or overexpression of NF-κB 
has been linked to resistance to apoptosis, stimulation of proliferation and neoplastic 
transformation in cells. Similarly, functional activation of AP1 also results in malignant 
transformation and tumor promotion. A vast group of phytochemicals target these two 
cellular-signalling cascades to suppress the gene expression associated with 
carcinogenesis (49, 50). Epigallocatechin gallate (EGCG), genistein, resveratrol, 
curcumin, [6]-gingerol and capsaicin have been suggested as involved in MAPKs and its 
downstream pathways (28). 
 
Evidence of Chemoprevention from Dietary Substances 
It is believed that 90-95% of cancer is related to our diet and environment, only 
5-10% is genetic (3). More than adequate intake of red meat, processed meat (31), 
saturated fat, fried foods, or salt-preserved foods, inadequate intake of vegetables and 
fruits (28), and abuse of alcohol (29) are risk factors of cancer. On the other hand, 
consumption of green tea, colored vegetables and fruits, and whole grains reduces risk of 
some types of cancer (51, 52). 
Increased intake of fruits and vegetables has been associated with lower 
occurrence of lung, stomach and colon cancer (4, 5). In a large nutrition cohort study 
performed in the US from 1992 to 1997, a 30% reduction in colon cancer risk was 
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observed in men with the highest vegetable intakes (>3.3 servings) per day (6). The 
study also suggested that very low intakes of plant foods may increase colon cancer risk. 
High intakes of glucosinolates, indoles, β-carotene, lutein, lycopene and vitamin C 
phytochemical subgroups may decrease colon cancer risk. 
Mediterranean diets high in fruit, cereals, olive oil as the main source of fat, and 
relatively low in meat and dairy products (53, 54) have been linked with lower incidence 
of GIT cancer (55). De Lorgeril and others (56) found a 61% reduction of all-site cancer 
risks in French coronary heart disease patients consuming a Mediterranean diet. Gallus 
and others (57) identified consumption of fruits and vegetables, fish, wholegrain foods 
and olive oil in a typical Mediterranean diet as potential protective factors against 
cancer, especially digestive tract cancer. A case control study in Italy by la Vecchia and 
others (58) showed that consumption of olive oil and other unsaturated oils and fish were 
preferable over saturated oil, red meat and refined carbohydrates in terms of lowering 
the risk of epithelial cell cancers. Dietary antioxidants such as β-carotene, vitamin E and 
minerals, such as calcium, showed an inverse relationship with breast cancer risk. 
Bosetti et al. (59) investigated the diversity of the components of Mediterranean diet and 
upper gastrointestinal tract cancer risk in three epidemiological studies in Italy. They 
reported a lower risk of upper aerodigestive tract cancers in people whose diet contained 
at least six of the components in a typical Mediterranean diet related to those that 
contained less than three.  
An epidemiological study revealed that drinking over 10 Japanese-size cups 
(about 80–120 ml) of green tea per day delayed the average age of cancer onset in Japan. 
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The recurrence of human breast cancer was also delayed with increased consumption of 
green tea (60-62). Experiments performed on tumorigenesis in APC mice showed that 
green tea polyphenol extracts, such as epigallocatechin gallate (EGCG), decreased 
proliferation and induced apoptosis in tumor cells (63). 
 
Whole Grains and Chemoprevention 
Cereals are the edible seeds or grains of the grass family, Gramineae. The 
predominant cereals consumed around the world are wheat, rice, corn (maize), millets, 
oats, rye, sorghum and barley. Cereals provide mainly carbohydrate, protein, fiber as 
well as vitamins (mainly E and B family) and minerals (zinc, magnesium and selenium) 
in the diet (64). The anatomical structure of all cereals is similar: the grain is made up of 
three components, the endosperm, the germ and the bran. Though the endosperm 
constitutes almost 80% of the whole seed and provides protein and starch, the bran and 
the germ account for most vitamins, minerals and phytochemicals (65, 66). Whole grain 
products use all three parts in processing. The Food and Drug Administration requires 
products to be low-fat and contain at least 51% whole grains by weight, to make the 
“whole grain” claim on the label (67). 
Epidemiological studies reveal a strong protective effect of whole grain food 
against GIT cancers (10). Jacobs and co-workers (10) concluded that intake of whole 
grain foods consistently reduced the risk of oral cavity and pharynx, oesophagus, 
stomach, colon, rectum and liver neoplasms by 30–70 %. A cohort study among 34,651 
postmenopausal women showed that intake of a high amount of whole grains (7 servings 
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per day) and yellow/orange vegetables (0.5 serving per day) was inversely related to risk 
of overall upper aerodigestive cancers, such as oropharyngeal, laryngeal, 
nasopharyngeal/salivary, esophageal and gastric cancers (12). A case-control study in 
Switzerland found that consumption of whole grain cereals correlated with decreased 
risk of cancer of the oral cavity and pharynx, esophagus and larynx. In contrast, refined 
grains were associated with higher risk of these cancers (68). A population-based cohort 
study among Swiss women concluded that high consumption of whole grain (>4.5 
servings per day) could reduce the risk of colon cancer (69).  
Whole grains may contribute to cancer prevention by stimulating a healthy gut 
environment, with dietary fiber providing antioxidants (66), potentially binding of 
carcinogens, modulating glycemic response, and producing hormone like effects (from 
phytoestrogens) (65).  
Complex carbohydrates in grains may lower the risk of large bowel cancer (70). 
Insoluble non-starch polysaccharides, resistant starch, and oligosaccharides are large 
bowel laxatives, microflora fermentation substrates and prebiotics that promote gut 
health (70). Dietary fiber can be fermented in the gut, producing short-chain fatty acids 
(SCFA), which lower colonic pH. They also serve as an energy source for colonocytes 
and may alter blood lipids. These improvements in the gut environment may provide 
immune protection beyond the gut (71). Dietary fiber is also protective by diluting or 
adsorbing carcinogens (72), reducing colonic transit time, and altering bile acid 
metabolism (73).  
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An inverse relation between intake of dietary fibers and incidence of large bowel 
cancer was observed (7). It suggested that colorectal cancer risk could be reduced by 
40% by increasing fiber consumption from 15 g to 30 g per day (7). McIntyre and others 
(74) found that rats fed with wheat bran and oat bran had a lower incidence of large 
bowel cancer than rats fed with non-fiber diets. Butyrate produced by gut microflora 
through fermenting fiber in bran was proposed as the preventive mechanism.  
Various phytochemicals and minerals present in whole grains provide antioxidant 
benefits to the gastrointestinal tract epithelia. Important groups of phytochemicals found 
in whole grains are phenolics, carotenoids, vitamin E compounds, lignans, β-glucan, and 
inulin (75). Major antioxidant minerals in cereals are Zinc and Selenium (64). A16-year 
follow up study in 34,708 postmenopausal women in Iowa indicated that zinc intake was 
negatively related to upper digestive tract cancer (76). Whole grain phytochemicals, such 
as ferulic acid and diferulates, complement those in fruits and vegetables. The 
antioxidant compounds in grains are mainly substituted benzoic and cinnamic acid 
compounds, caffeic and ferulic acid esters of long chain mono and dialcohols, 
tocopherols, and flavonoids (75). Most of these phytochemicals are bound to cell wall 
materials (75). Due to their insolubility, whole grain phytochemicals survive digestion in 
the upper gastrointestinal tract and reach the colon. Thus colonic microflora digestion 
may release them and make them available (77). For example, ferulic acid and diferulic 
acids from cereal bran can be released by gastrointestinal esterase from intestinal 
mucosa and microflora (78). Dietary fiber, condensed tannins and phytic acids may bind 
excessive iron and heavy metals in diet thus provide antioxidant benefits (65). 
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Phytoestrogens present in legumes, whole grains, fruits, and vegetables could 
induce detoxifying phase II enzymes hence provide chemopreventive effects. Jacobs and 
others (79) concluded that consuming whole grains in the diet regularly could increase 
serum enterolactone concentrations, which has been associated with reduced cancer risk 
(80). The elevated enterolactone concentrations in serum was mainly due to breakdown 
of the lignans contained in the whole grains (81). Wang et al. (82) determined the 
capacity of enterolactone to induce NAD(P)H:quinone oxidoreductase (QR) in human 
colon cancer cells and found a 6-fold induction of QR activity at 10.0 μM of 
enterolactone.  
Whole grains reduce glycemic index and glycemic loads while refined 
carbohydrates elevate them. A persistent high glycemic load from the diet causes 
abnormal glucose metabolism and probably dyslipidemia, which are risk factors for 
many chronic diseases (83, 84). A case-control study in Italian women showed an 
inverse association between glycemic index, and glycemic loads of the diet and 
colorectal cancer risk (85). 
 
Chemoprevention Potential of Sorghum 
Sorghum (Sorghum bicolor) is the fifth most important cereal crop in the world 
(86). It is a staple food and important cereal in many parts of Africa, Asia, and the 
Middle East (65). Sorghum in these areas is mainly consumed in the forms of couscous, 
porridge, baked goods (bread, flat bread, cookie, and steam bread), and fermented 
drinks. Sorghum is an important alternative grain to use in gluten-free diets (87). 
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Sorghum is fairly resistant to pests and diseases, which is partly linked to its unique 
profile of phytochemicals (88). 
In Africa and parts of Asia, regular consumption of sorghum and millets was 
associated with lower esophageal cancer incidence compared to areas where wheat and 
corn were the major cereals consumed (15, 18). Chen and others (17) reported a 
correlation between decreased incidence of esophageal cancer and consumption of 
sorghum and millet as opposed to corn and wheat in the diet in Shanxi province, China. 
Isaacson (16) proposed that the increase in esophageal cancer among South African 
blacks was due to their substitution of sorghum with corn as a staple diet. These 
observations suggested that sorghum and/or sorghum components have preventive 
properties against esophageal cancer that other cereal grains do not possess. It is possible 
that this beneficial effect could extend to other GIT cancers. However, information on 
the possible mechanisms of sorghum chemoprevention and the components of sorghum 
that contribute to this effect are limited.  
Phenolic acids (89, 90) and flavonoids (3-deoxyanthocyanins (91, 92), flavones 
(93), flavanones (93), and condensed tannins (94)) have been found in sorghum. The 
total phenol contents in colored pericarp sorghums ranged from 6.4-19.8 mg gallic acid 
equivalent (GAE)/g (95). Total phenol content of brans from those sorghums ranged 
from 19.9-66.3 mg GAE/g (95). Total phenols in sorghum are higher than other common 
cereal grains, such as wheat (0.5-0.6 mg GAE/g), barley (0.9 mg GAE/g), millet (1.4 mg 
GAE/g), and rye (1.0 mg GAE/g) (96, 97). 
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Two classes of phenolic acids, hydroxybenzoic acids and hydroxycinnamic acids, 
are the major phenolic acids in sorghums (98). Free phenolic acids are found in the outer 
layers of the kernel while bound phenolic acids are attached to the cell walls of the grain 
matrix. The ratio of free to bound phenolic acids range from 1:2-1:5, depending on the 
varieties (89). 
Sorghum flavonoids include 3-deoxyanthocyanins (apigeninidin, luteolinidin and 
their derivatives) (91, 92), flavones (apigenin, luteolin) (99), flavanones (eriodictyol 
(100), naringenin (101)), flavonols (kaempferol 3-rutinoside-7-glucuronide (91), 
dihydroflavonols taxifolin (93), taxifolin 7-glucoside (93)), and flavan-4-ol compounds 
(luteoforol, apiforol) (102).  
Based on appearance and total extractable phenols, sorghums can be classified as 
white (with no detectable tannins or anthocyanins and very low levels of phenols); red 
(with no tannins but significant levels of phenols and a red pericarp); black (with very 
high levels of 3-deoxyanthocyanins and a black pericarp) and tannin sorghums (with 
significant levels of tannins and different degrees of pericap pigments) (86). The high 
pigment content in black pericarp sorghums were correlated with high antioxidant 
capacity (86). 
The pigments from black pericarp sorghums, 3-deoxyanthocyanins, are unique 
compared to anthocyanins from other plant sources. The 3-deoxyanthocyanins lack a 
substitution at the  C-3 position of the C-ring, which makes them more stable as 
colorants (103, 104), and more cytotoxic than their anthocyanin analogs (19). 3-
Deoxyanthocyanins identified in sorghum mainly include apigeninidin, luteolinidin (86, 
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92, 105); their glucosides, apigeninidin-5-glucoside and luteolinidin-5-glucoside (91, 92, 
105); acylated forms (106, 107); and methoxylated derivatives, 5-methoxyluteolinidin, 
7-methoxyapigeninidin, 5-methoxyluteolinidin-7-glucoside (105), 5-
methoxyapigeninidin, 7-methoxyluteolinidin (99), and 7-methoxyapigenidin-5-glucoside 
(105, 108). Black pericarp sorghum has the highest level of 3-deoxyanthocyanins 
ranging from 173-1054 μg/g; red pericarp sorghum contains 32-180 μg/g; lemon-yellow 
and white pericarp sorghum have very low level of 3-deoxyanthocyanins (109). 
Compared with other pigmented cereal grains, black sorghum has similar content of 
anthocyanins as purple corn (965 μg/g) and at least twice the level in pink (93 μg/g), red 
(558 μg/g), and blue corns (225 μg/g), blue barley (4 μg/g), and blue (106-156 μg/g) and 
purple wheat (13-139 μg/g) (96, 110). 
 Condensed tannins, also known as proanthocyanidins, are high-molecular weight 
polyphenols that consist of polymerized flavan-3-ol and/or flavan-3,4-diol units (98). 
Tannins in sorghum are of condensed type. Because of their ability to bind free radicals, 
sorghums containing tannins have higher antioxidant capacity than most non-tannin 
sorghums (86).  
 Different genotypes of sorghum with a wide range of phenol profiles have been 
recognized as strong free radical scavengers in vitro (109). The antioxidant capacity 
(evaluated by ABTS) of sorghums, especially black and high tannin sorghums (75-340 
μmol Trolox equivalent /g) are the highest among common cereals such as 
red/purple/white wheat (20-30 μmol Trolox equivalent /g), barley (10-40 μmol Trolox 
equivalent /g), finger and pearl millets (40-50 μmol Trolox equivalent /g), black/red rice 
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(50-120 μmol Trolox equivalent /g), and blue/red/yellow corn (20-30 μmol Trolox 
equivalent /g) (96, 97). 
Antioxidant capacity is insightful in evaluating chemopreventive potential 
because antioxidants can block initiation of carcinogenesis by scavenging or reduce the 
oxidative species and/or carcinogens. Different genotypes of sorghum with a wide 
phenol profile have been recognized as strong free radical scavengers.  Brans from 
tannin sorghum, red, black and white pericarp sorghum varieties exhibited anti-
inflammatory potential (111). Hence sorghum phenols may have a potential in 
chemoprevention. It is necessary to determine how composition affects their ability to 
prevent carcinogenesis and/or inhibit cancer growth. 
  
Methods for Evaluating Chemopreventive Potential of Phytochemicals 
 
Antioxidant (Free Radical Scavenge) Capacity Assays 
Free radical (or oxidant) scavenging assays determine how effective an 
antioxidant is at preventing initiation and prolongation of radicals or oxidation (112). 
Free radical scavengers have strong potential to block the insults from carcinogens and 
oxidative stress (21). Antioxidant assays are divided into two major categories: single 
electron transfer reaction based assays (ET) and hydrogen atom transfer reaction based 
assays (HAT) (112).  
The ET-based assays involve one redox reaction between the antioxidant and the 
oxidant (also as the probe for monitoring the reaction). The oxidant attracts an electron 
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from the antioxidant then changed color. The color change is proportion to the 
concentration of the antioxidant (112). The ET-based assays include DPPH (diphenyl-1-
picrylhydrazyl) radical scavenging capacity (113), FRAP (ferric ion reducing antioxidant 
parameter) (114), and TEAC (Trolox equivalent antioxidant capacity) also known as 
ABTS (2,2’-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (115) assay. Because of 
lack of a competitive reaction between the antioxidant and an oxygen radical in ET-
based assays, it is assumed that antioxidant capacity measured by these assays is indeed 
the reducing capacity of the compound (116). 
The HAT-based assays generally evaluate how competitive an antioxidant is to 
trap free radicals. Major assays in this category include TRAP (total radical trapping 
antioxidant parameter) assay (117), ORAC (Oxygen Radical Absorbance Capacity) 
assay (118), IOU (inhibited oxygen uptake) assay (119), and inhibition of linoleic acid 
oxidation assay (120). Those assays monitor the kinetic competitive reaction in a system 
composed of a synthetic free radical generator, an antioxidant and a probe (also an 
oxidant) to indicate the progress of the reaction; and quantitation is derived from the 
kinetic reaction curve (112). 
Among these assays, ABTS and ORAC assay are common methods used to 
evaluate free radical scavenging capacity and were demonstrated as suitable methods to 
evaluate phenolic compounds (95, 121, 122). The ABTS assay is based on the capacity 
of a compound to donate an electron to react with the probe ABTS, which causes a color 
change in the probe (112). The ABTS assay is relatively easy, fast, and inexpensive to 
perform. The ORAC assay was developed to directly assess the capacity of the 
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antioxidants to inhibit the oxidation of the molecular probe (fluorescein) by monitoring 
the kinetics of the reaction. The ORAC assay evaluates the radical chain-breaking 
antioxidant capacity. In general, ORAC assay applies a thermal radical generator (2,2’-
azobis(2-amidinopropane) dihydrocloride, AAPH) to give a steady flux of peroxyl 
radicals in air-saturated solution. An antioxidant competes with probes (fluorescein) for 
the radicals and inhibits or retards the probe oxidation (112, 118). Though the ORAC 
assay takes a relatively longer time to gather results and expensive instrument to 
complete analysis, its procedure is standardized hence results over different laboratories 
can be compared. 
 
Phase II Enzyme Inducing Capacity Assays 
Potential to activate cellular actions to block cancer initiation is an important 
aspect of chemoprevention (45). Determining phase II enzyme inducing capacity of a 
compound is an established method to determine its capacity to activate the ARE 
protective pathways (123). Phase II enzymes include glutathione- 
s-transferase (GST), UDP-glucuronyltransferases (UGTs), NAD(P)H: quinone 
oxidoreductase (QR) and heme oxygenase (HO-1) (124). Methods to evaluate phase II 
enzyme inducing capacity can target different sites along the synthesis and expression of 
these enzymes, such as measuring gene expression, measuring the amount of enzyme 
protein, or determining enzyme activity (45, 124).  
NAD(P)H: quinone oxidoreductase (QR), a model phase II enzyme, promotes the 
obligatory two electron reduction of quinones to hydroquinones, which are then 
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degraded by glucuronidation. Thus QR protects cells from the toxicity of quinones and 
their metabolic precursors (125). One method to evaluate QR enzyme inducing capacity 
in vitro has been developed using murine hepatoma cell lines (123).  
 
Cancer Cell Proliferation Inhibition Assays 
Chemopreventive compounds have the potential to suppress the promotion and 
progression of malignant cells. Evaluating the potential of a compound to directly inhibit 
cancer cell proliferation determines the efficacy of the compound to suppress preformed 
tumors. Many assays are available to determine cell proliferation, for example, 
radioactive assays based on the capacity of viable cells to incorporate isotopes (such as 
[3H]-thymidine, [3H]uridine) into  nucleic acids (126), measurement of nucleic acid and 
adenosine triphosphate (ATP) contents in lysed cells (127), and colorimetric assays 
based on the capacity of living cells to reduce a chemical (such as Alamar blue (128) and 
tetrazolium dyes (129)) then measure the color change.  
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay is a 
commonly used non-radioactive method to determine proliferation of cultured cells. The 
MTT assay (129) is based on the ability of a mitochondrial dehydrogenase enzyme from 
viable cells to cleave the tetrazolium rings of the pale yellow MTT to form dark blue 
formazan crystals, thus accumulates within healthy cells. The crystals formed are largely 
impermeable to cell membranes. The number of surviving cells is directly proportional 
to the level of the formazan product created. Adding a detergent to the system solubilizes 
the cells and the crystals at the same time. Then the color is quantified using a multiwell 
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scanning spectrophotometer (130-132). The MTT assay is easy and not labor intensive to 
perform. However, several reports have indicated that for some agents and cell lines, an 
increase of MTT reduction was observed without increased cell viability; e.g. with drug 
efflux inhibitors (133), ursolic acid (134), resveratrol (135), and high Abl kinase activity 
tumor cell lines (136). Hence it is important to use complementary cell viability assays 
along with MTT assay. 
Cell proliferation can also be determined by measuring double-stranded DNA 
(dsDNA) content by fluorescent dyes (137). PicoGreen is a fluorescent probe that 
specifically binds to dsDNA. PicoGreen assay has a high sensitivity for measuring 
dsDNA (25 pg/mL dsDNA) (138, 139). Double-stranded DNA content is considered as a 
stable parameter in cells and the estimated dsDNA content from PicoGreen assay varies 
depending on the cell cycle of a tested culture (140), hence it is a reliable indicator of 
cell proliferation. 
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CHAPTER III 
MATERIALS AND METHODS 
 
Sorghum Samples 
Seventeen sorghum varieties were screened for phenolic profile and antioxidant 
capacity. Among the 17 samples, some were selected for further cell culture studies. The 
samples included six tannin sorghums (Sumac, Hi-tannin (College Station, TX 2002); 
Seredo, Cadam and CR 35 (KARI, Kenya 2006); Black PI Tall (College Station, TX 
2005), and 11 non-tannin sorghums selected based on different pericarp pigmentation: a 
black variety Tx430 (College Station, TX 2002), a commercially grown red variety from 
Missouri (Columbia, MO 2006) (“Mizzou”), three red varieties Tx2911, 98BRON155, 
and 99LGWO50 from Texas (College Station, TX 2008), a light red variety I CSV III 
from Kenya (KARI, Kenya 2006), two lemon yellow varieties SC748 and EBA3 
(College Station, TX 2008), and three white varieties: KARI-Mtama (KARI, Kenya 
2006), a commercially grown variety from Missouri (Columbia, MO 2006) (“Mizzou 
white”), and ATX635 × RTX436 (College Station, TX 2001). White commercial dent 
corn was used as a control because of its low phenol and carotenoids content. Sorghum 
grains were kept at -35°C till used. 
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Reagents and Experimental Materials 
 
Chemicals and Reagents 
3-Deoxyanthocyanidin standards, apigeninidin, luteolinidin, 7-
methoxyapigeninidin, 7-methoxyluteolinidin, 5-methoxyapigeninidin, 5,7-
dimethoxyapigeninidin and 5,7-dimethoxyluteolinidin were obtained from AlsaChim 
(Strasbourg, France). Figure 1 shows the structures of 3-deoxyanthocyanidin standards 
and the abbreviations used in this thesis. Genistein and sulforaphane were purchased 
from Sigma-Aldrich (St. Louis, MO). 
Hexane, acetone, ethanol, methanol, hydrochloride acid (HCl), Folin-Ciocalteu 
reagent, ethanolamine, potassium phosphate, sodium chloride (NaCl), sodium dodecyl 
sulfate (SDS), crystal violet, Tris, and Tween-20 were of analytical grade and purchased 
from Fisher (Fisher Scientific, Fair Lawn, NJ). Gallic acid, catechin hydrate, vanillin, 
ABTS (2,2’-azinobis(3-ethylbenzothiazoline-6-sulfonic acid), potassium persulfate, 
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide], sodium 
fluorescein, 2,2’-azobis(2-amidinopropane) dihydrochloride (AAPH), 6-hydroxy-
2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), flavin adenine dinucleotide 
(FAD), β-nicotinamide adenine dinucleotide phosphate (NADH), and bovine serum 
albumin were purchased from Sigma-Aldrich (St. Louis, MO). Dimethyl sulfoxide 
(DMSO), ethylenediaminetetraacetic acid (EDTA) and digitonin were purchased from 
Acros Organics (Acros Organics, NJ). Menadione was purchased from Alexis 
Biochemicals (San Diego, CA). Dicoumarol was from EMD Biosciences (EMD 
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Biosciences, Inc., La Jolla, CA). Glucose-6-phosphate and yeast glucose-6-phosphate 
dehydrogenase were from MP Biomedicals (Solon, Ohio).  
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Figure 1. Skeleton structures of 3-deoxyanthocyanidins used in this study. 
 
 
 
 
Compound Abbreviation R1 R2 R3 
Apigeninidin Api H H H 
5-methoxyapigeninidin 5-Api H CH3 H 
7-methoxyapigeninidin 7-Api H H CH3 
5,7-dimethoxyapigeninidin 5,7-Api H CH3 CH3 
Luteolinidin Lut OH H H 
7-methoxyluteolinidin 7-Lut OH H CH3 
5,7-dimethoxyluteolinidin 5,7-Lut OH CH3 CH3 
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Cell Lines 
Two human gastrointestinal carcinoma cell lines were selected to represent the 
upper digestive tract (esophagus) and lower digestive tract (colon), which are common 
gastrointestinal tract cancer sites. The OE33 (a cell line established from the 
adenocarcinoma of the lower esophagus of a 73-year-old female patient) was purchased 
from Sigma (St. Louis, MO); HT-29 (a cell line established from colorectal 
adenocarcinoma of a 44-year-old female patient) was purchased from the American 
Type Culture Collection (ATCC, Manassas, VA).  
Murine hepatoma Hepa 1c1c7 (a murine hepatoma cell line derived from C57/L 
mouse) was purchased from ATCC (Manassas, VA). This cell line is useful for studying 
aryl hydrocarbon receptor and P450IA1 regulation. It has been used as a standard cell 
line in testing the inducing capacity of a compound to induce cellular NAD(P)H:quinone 
oxidoreductase activity.  
 
Cell Culture Materials 
Media used included α-MEM (minimum essential medium) (with 2mM L-
glutamine without ribonucleosides or deoxyribonucleosides), McCoy’s 5A medium 
(with 1.5mM L-glutamine) and RPMI 1640 medium (with 2mM L-glutamine). Media 
were purchased from Invitrogen (Carlsbad, California) and kept at 4 °C till use. Fetal 
bovine serum (FBS) was obtained from Atlanta Biologicals (Lawrenceville, GA). 
Dulbecco's phosphate-buffered saline (DPBS) and 0.05% trypsin were purchased from 
Invitrogen (Carlsbad, CA).  
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Three types of plates were used to culture cells: 96-well all clear tissue culture 
plates (FALCON, Franklin Lakes, NJ), 96-well black with clear bottom tissue culture 
plates (Costar) and regular all black 96-well plates (Costar, Corning Incorporated, NY). 
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] cell 
proliferation assay kit was purchased from ATCC (Manassas, VA). Quant-iT PicoGreen 
dsDNA assay kit was purchased from Invitrogen (Carlsbad, CA).   
 
Preparation of Crude Sorghum Extracts 
Whole kernels of sorghum grain were ground in a cyclone mill (UDY, Boulder, 
CO) to pass through 0.1 mm screen before extraction. Ground samples were defatted 
using hexane at a ratio of 1:2 (w:v) by stirring for 2 h. The mixture was then centrifuged 
at 3100 ×g and the residue was dried inside a fume hood over night at room temperature. 
Defatted samples were extracted with 70% (v/v) aqueous acetone with stirring for 30 
min. Supernatant was collected by centrifuging (3100 × g) for 15 min at 4 °C. Acetone 
was immediately removed from the supernatant under vacuum at 40 °C. The aqueous 
phase was freeze-dried and used as a crude extract. Extracts were kept at -35°C till use. 
 
Gross Phenolic Profile 
Ground grain samples were extracted with 1% HCl in methanol for 2 h to 
measure total polyphenol, tannin, and 3-deoxyanthocyanin contents. Freeze-dried crude 
sorghum extracts were dissolved in 1% HCl in methanol for these assays.  
 
 30
Phenol Content 
The Folin-Ciocalteu method described by Kaluza et. al. (141) was used. Aqueous 
samples (0.1 mL) was added into 1.1 mL distilled water then reacted with 0.4 mL Folin 
reagent and 0.9 mL 0.5 M ethanolamine for 20 min at room temperature. The absorbance 
was then read at 600 nm. Serial dilutions of gallic acid (0, 5, 10 15, 20, 25 mg/mL in 
methanol) was used as standards. Results were calculated and expressed as mg gallic 
acid equivalent (GAE)/g sample.  
 
Condensed Tannin Content 
The vanillin-HCl method described by Price et. al. (142) was used. Aqueous 
samples (1 mL) was added to 5 mL vanillin reagent (0.01 g/mL vanillin in methanol 
mixed with equal volume 8% HCl in methanol) and allowed to react for 20 min at 35 °C; 
a blank was prepared under the same reaction condition by reacting 1 mL the same 
aqueous sample with 5 mL 4% HCl in methanol. Absorbance was read at 500 nm and 
blank for each sample was subtracted. Serial concentrations of catechin (0, 0.2, 0.4, 0.6, 
0.8, and 1.0 mg/mL in methanol) were used as standards. Results were calculated and 
expressed as mg catechin equivalent (CE)/g sample.  
 
3-Deoxyanthocyanin Content 
The method used was first described by Fuleki and Francis (143) and further 
detailed by Awika et al. (144). Absorbance of sorghum grain samples and extract 
samples were read at 480 nm. The concentrations of 3-deoxyanthocyanins were 
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calculated based on the absorbance of luteolinidin at 480 nm using the Lambert-Beer’s 
Law: A = ε CL, where A is the absorbance at 480 nm, ε is the molar extinction 
coefficient (ε) of luteolinidin, C is sample concentration, L is the pathlength, which is 1 
cm. The 3-deoxyanthocyanin content of a sample was calculated based on the formula   
C (mol/L) = A/ ε. The mg luteolinidin equivalent of a sample = A/ ε × 103 × 270 × 
dilution factor, where 270 is the molecular weight of luteolinidin and molar extinction 
coefficient (ε) of luteolinidin used was 29,157 (145). 
 
Antioxidant (Free Radical Scavenging) Capacity Assays 
Antioxidant (Free radical scavenging) capacity was measured by ABTS (2,2’-
azinobis(3-ethylbenzothiazoline-6-sulfonic acid) and Oxygen Radical Absorbance 
Capacity (ORAC) assays. Ground grain samples were extracted in 70% aqueous acetone 
for 2 h and were used immediately in these assays. Freeze-dried sorghum crude extracts 
were dissolved in 70% acetone to be used in these assays. For both assays, the methods 
were described by Awika et al. (95).  
 
ABTS Assay 
The ABTS stock solution was prepared by reacting equal volume of 8 mM ABTS 
with 3 mM potassium persulfate in the dark for at least 12 h. The ABTS working 
solution must be prepared right before the assay by diluting 5 mL ABTS stock solution 
with 145 mL of pH 7.4 PBS buffer. The original absorbance of ABTS working solution 
at 734 nm should be around 1.5. Aqueous sample (0.1 mL) was added with 2.9 mL 
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ABTS working solution then allowed to react in the dark for 30 min at room 
temperature. The absorbance was read at 734 nm. A series dilution of Trolox (0, 100, 
200, 300, 400, 500, 600, 700, 800, 1000 μM in methanol) was used as standards. 
Antioxidant capacity was calculated and expressed as μmol Trolox equivalent /g sample.  
 
ORAC Assay 
The ORAC assay was conducted using a solid black 96-well plate and the 
reaction was monitored by a Biotek Synergy HT plate reader with automatic dispenser 
(Biotek, Winooski, VT). Sodium fluorescein working solution (4 × 10-3 μM), AAPH 
(153 mM), Trolox standards (0, 6.25, 12.5, 25, 50, 100 μM) were prepared using PBS 
buffer (pH 7.4) right before performing the assay. Aqueous samples (25 μL) and Trolox 
standards (25 μL) were analyzed in triplicate on the same plate. Sodium fluorescein 
working solution (150 μL) was added to each well before the whole plate was incubated 
inside the plate reader at 37 °C for 30 min. One aliquot (25 μL) of 153 mM AAPH was 
automatically dispensed into each well as the free radicals generator to start the reaction 
after incubation. Fluorescence readings (excitation 485 nm, emission 528 nm) was taken 
every minute from the time AAPH was added for 90 min. Antioxidant capacity was 
calculated based on the area under the fluorescence curve (AUC),  
AUC = 0.5 + (R2/R1) + (R3/R1 ) + (R4/R1) + . . . + (R90/R1) , where Rn is the fluorescent 
reading at the nth minute. 
A Trolox standard curve was obtained by plotting the concentrations of Trolox 
standards versus their AUC. Trolox equivalent of each sample was obtained by 
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interpolating the AUC of sample into the Trolox standard curve. The antioxidant 
capacity of ORAC assay was expressed as μmol Trolox equivalent / g. Each sample was 
measured on three different plates at three separate times. 
 
Cell Culture  
 
General 
Murine hepatoma cells Hepa 1c1c7 were cultured in Gibco α-MEM medium 
supplemented with 10% fetal bovine serum. Human colon carcinoma cells HT-29 were 
cultured in Gibco McCoy’s 5A medium supplemented with 10% fetal bovine serum. 
Human esophageal carcinoma cells OE33 were cultured in Gibco RPMI 1640 medium 
supplemented with 10% fetal bovine serum. Cell lines were subcultured every 3 or 4 d 
and incubated in a humidified incubator with 5% CO2 at 37 ºC. 
 
Preparation of Treatment Media 
Sorghum extract stocks were prepared by dissolving crude sorghum extracts in 
500 μL DMSO then diluted with DMSO into serial concentrations (5-800 mg/mL). 
Treatment medium was prepared by adding stocks at a ratio of 1:1000 (v/v) to 
corresponding growth medium. Final treatment medium contained 5-800 μg/mL crude 
sorghum extracts. Sorghum 3-deoxyanthocyanidin standard stocks (0.2-200 mM) and 
treatment medium were prepared by the same method. Final treatment medium 
contained 0.2-200 μM 3-deoxyanthocyanidins. 
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NAD(P)H:Quinone Oxidoreductase (QR) Inducing Capacity and Cytotoxicity 
Assay 
This assay measured QR activity in both sample-treated and control cells. The 
QR activity was measured through the NAD(P)H-dependent QR oxidized menadiol-
mediated reduction of MTT. Figure 2 shows the schematic principle of this assay. 
 
 
 
 
Figure 2. Principle of the NAD(P)H: quinone reductase (QR) activity assay (adapted 
from Prochaska and Santamaria (146)). Glucose-6-phosphate and glucose-6-phosphate 
dehydrogenase continually generate NADPH, which is used by QR to transfer electrons 
to menadione. Menadione further transfers this electron to MTT then produces blue 
reduced MTT formazan dye, which can be measured at 610 nm. Both NADPH and 
menadione are regenerated, which obviates problems encountered with substrate 
depletion (146).  
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NAD(P)H:Quinone Oxidoreductase (QR) Inducing Capacity Assay 
The Hepa 1c1c7 cells were cultured in growth medium (α-MEM medium 
supplemented with 10% fetal bovine serum) for 72 h before plating into a clear 
FALCON 96-well tissue culture plate at a density of 10,000 cells/well with 200 μL 
growth medium. The cells were incubated at 37 ºC with 5% CO2 for 24 h before 
exposure to treatment media.  
Six different treatments and one control were applied onto one 96-well plate. 
Each treatment was assigned to 12 wells while control was assigned to 16 wells, and the 
remaining 8 wells were blanks. Final treatment medium contained 5-400 μg/mL 
sorghum crude phenol extracts or 0.2-200 μM 3-deoxyanthocyanidin standards. Each 
well received 200 μL treatment medium while control cells received 200 μL growth 
medium containing 0.1% DMSO. The cells were grown for another 24 h (37°C, 5% 
CO2) before QR activity assay. After 24 h incubation, the medium in each well was 
aspirated and the cells were lysed with 50 μL 0.8% digitonin in 2 mM pH 7.8 EDTA, 
incubated for 10 min at 37 ºC then agitated on a shaker for another 10 min at room 
temperature. Lysed cells were used for QR activity assays. 
Each treatment set was then divided into three different assays to evaluate 
different aspects of QR activity. The three assays were: 1) standard enzyme activity 
assay, 2) prior stop enzyme activity assay, and 3) minus menadione assay.  
Standard enzyme activity assay evaluates the proportion of MTT reduction 
attributable to QR activity. MTT, a pale yellow tetrazolium dye, is reduced to its blue 
formazan form, which can be measured by the absorbance at 610 nm. Prior stop enzyme 
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activity assay evaluates the proportion of MTT reduction not attributable to QR activity. 
Since menadione is used in these two assays mentioned above as an electron transporter 
to MTT, minus meadione assay determines the proportion of MTT reduction attributable 
to QR activity but without menadione as an electron transporter. True cellular QR 
activity is determined using the QR activity obtained from standard enzyme activity 
assay subtracting the activity obtained from prior stop enzyme activity assay and minus 
menadione assay.  
A baseline reaction solution was prepared for each set of QR activity assays. The 
composition of the baseline reaction solution was as follows: 5% (v/v) 0.5M Tris-HCl 
(pH 7.4), 6.67% (v/v) 1.5% Tween-20, 0.67% (v/v) 7.5mM FAD, 0.06% (v/v) 50mM 
NADP, 66.7% (g/L) bovine serum albumin,  30% (g/L) MTT, 6.67% (v/v) 150 mM 
glucose-6-phosphate (in 1% HCl acidified distilled water), 2 U/mL yeast glucose-6-
phosphate dehydrogenase, and distilled water to make up to the final volume. A 
standard reaction solution used for standard enzyme activity assay was made by adding 
1 μL of 50 mM menadione (dissolved in acetonitrile) per mL of baseline reaction 
solution just before the standard reaction solution was dispensed into the wells. 
Dicoumarol (0.3mM in 0.5% DMSO and 5mM potassium phosphate (pH 7.4)) served as 
the stop solution to stop QR activity. The three assays to determine cellular QR activity 
were carried out on the same plate and at the same time. Figure 3 shows a schematic 
process of the three assays. 
Once the cells were lysed, stop solution (50 μL) was first added to prior stop 
enzyme activity assay wells. Then 200 μL of standard reaction solution was added to 
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standard enzyme activity assay and prior stop enzyme activity assay wells. Finally 200 
μL of baseline reaction solution was added to minus menadione assay wells. The plate 
was then allowed to react in the dark for 5 min at room temperature. The reaction was 
arrested by dispensing 50 μL of stop solution to both standard enzyme activity assay and 
minus menadione assay wells. The plate was then read in the BioTek Synergy HT Plate 
Reader at 610 nm. Absorbance of all the solutions from the standard enzyme activity 
assay was taken as blank reading. 
 
Cytotoxicity Assay (Crystal Violet Assay) 
Since samples screened for QR inducing activity could also suppress growth of 
the cells, thus affecting results, cell population was measured by the crystal violet assay 
(146). Plates were treated identically as for the QR inducing activity assay. After the 
cells were incubated with treatment medium for 24 h, the medium was decanted. Then 
200 μL of 0.2% crystal violet in 2% ethanol was dispensed into each well to stain the 
cells for 10 min at room temperature. The plate was rinsed 3 times with distilled water. 
Bound dye was solubilized by adding 200 μL of 0.5% SDS in 50% ethanol in each well. 
The plate was then incubated at 37 ºC for 1 hour, and absorbance was read at 610 nm. A 
higher absorbance reading in treated cells than the control cells indicated cell growth 
induced by treatment; while a lower reading indicated a reduction of cell population due 
to treatment. Hence cell population was used to correct QR activity obtained from 
treatments. 
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Figure 3. Schematic process of NAD(P)H:quinone oxidoreductase (QR) activity assay 
according to Prochaska and Santamaria’s method (146).  
 
 
Calculating QR Inducer Ratios 
The QR inducer ratio determines how well a treatment could raise the cellular 
activity of QR compared with non-treated cells (controls). The QR inducer ratio was 
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calculated as the ratio of cellular QR activity obtained from each treatment to the cellular 
QR activity from the control treatment conducted on the same plate. The formula below 
was used: 
QR inducer ratio = (A610 of treatment – A610 of control on the same plate) / A610 of       
control on the same plate 
QR specific inducer ratio = treatment QR inducer ratio × treatment cell population / cell 
population of control for the treatment. 
 
Cancer Cell Proliferation Assay 
Both MTT and PicoGreen assays were used because of their non-radioactive 
nature, convenience and accuracy.  
 
MTT Assay 
The MTT assay is based on the ability of a mitochondrial dehydrogenase enzyme 
from viable cells to cleave the tetrazolium rings of the pale yellow MTT and form dark 
blue formazan crystals, thus resulting in its accumulation within healthy cells. The 
number of surviving cells is directly proportional to the level of the formazan product 
created. Adding a detergent into the system solubilized the cells and the crystals at the 
same time, which enabled the quantitative reading of the absorbance by a plate reader 
(130-132).  
Both HT-29 and OE33 cells were grown in growth medium (α-MEM 
supplemented with 10% FBS for HT-29 and McCoy’s 5A supplemented with 10% FBS 
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for OE33) for 72 h before plating into a clear FALCON 96-well tissue culture plate at a 
population of 2,000 cells/well with 100 μL growth medium. Final treatment medium 
contained 5-800 μg/mL crude sorghum extracts or 0.2-200 μM 3-deoxyanthocyanidin 
standards. The cells were incubated with treatment medium for 48 h. Each treatment 
used 4 wells and each well received 100 μL of treatment medium while control cells 
received 100 μL of growth medium containing 0.1% DMSO. After 48 h incubation, 
viable cells were determined using the ATCC MTT assay kit. The linearity of this MTT 
assay was 100-5000 cells per well (plated cell population, tested after 48 h incubation) 
for both cell lines. The MTT reagent (10 μL) was added to each well and incubated for 3 
h at 37 ºC; the medium was then decanted and 50 μL of DMSO was added to dissolve 
the purple crystals. Absorbance was read at 570 nm. Blank reading (10 μL of MTT 
reagent plus 50 μL of DMSO) was subtracted from each well. Sample blank reading was 
recorded as absorbance due to treatment medium only (without cells). Relative Growth 
(%) was calculated using the following formula:  
 Relative Growth (%) = (A570 of test sample – blank – sample blank)/A570 of control 
cells × 100 % 
 
Double-Stranded (ds) DNA Content: PicoGreen Assay 
Since the dsDNA content in each cell is constant, by determining the contents of 
dsDNA using Quant-iT PicoGreen dsDNA assay indicates the living cell population. 
Both HT-29 and OE33 cells were treated using the same protocol described for MTT 
assay above, except cells were plated in 96-well black plates with a clear bottom. After 
 41
48 hour incubation, the medium was aspirated and cells were washed twice with DPBS 
buffer to wash out dead cells floating in the medium. Each well then received 50 μL of 
0.05% trypsin in 0.9% NaCl solution to detach cells at 37 ºC for 1 hour. The plate was 
then frozen at -35 °C for 1 hour then thawed at room temperature to lyse cells. A 
standard curve of dsDNA (0, 1, 5, 10, 50, 100, 150 ng/well) was prepared in the same 
testing plate for each assay. Standard solution of dsDNA (100 μg/mL in 10 mM Tris-
HCl 1 mM EDTA, pH 7.5) were provided in the PicoGreen assay kit and diluted with 
0.05% trypsin in 0.9% NaCl solution. PicoGreen fluorescent dye working solution was 
prepared in 10mM Tris-1mM EDTA buffer provided in the PicoGreen assay kit. After 
lysing the cells, PicoGreen working solution (50 μL) was added to each well including 
the standards then the whole plate was incubated at room temperature in the dark for at 
least 5 min. Fluorescence was read in the plate reader at excitation 480 nm and emission 
520 nm. The content of dsDNA in each well was calculated using the standard curve 
obtained from each assay. Relative Growth (%) was calculated using the following 
formula:  
Relative Growth (%) = dsDNA content of treatment cells/dsDNA content of control cells 
× 100 %. 
 
Statistical Analysis 
Total phenol, condensed tannin, 3-deoxyanthocyanin pigment contents, ABTS 
and ORAC antioxidant capacity, and cancer cell growth inhibition assays were repeated 
three times. QR inducing capacity assay was repeated two times. Statistical analyses 
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were done using SPSS version 15.0 (SPSS Inc., Chicago, IL) with one-way Analysis of 
Variance (ANOVA). Post Hoc test (Dunnett’s, Fisher’s LSD, and Tukey’s HSD) after 
ANOVA was used to compare treatments means.  
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CHAPTER IV 
GROSS PHENOLIC PROFILES AND ANTIOXIDANT PROPERTIES OF 
SORGHUM GRAINS AND THEIR CRUDE EXTRACTS 
 
Gross Phenolic Profiles and Antioxidant Properties of Sorghum Grains 
 
Gross Phenolic Profiles of Sorghum Grains 
The seventeen varieties of sorghum showed a wide range of phenolic 
compositions (Table 1). Based on the presence of condensed tannins, the seventeen 
sorghum grains can be divided into two groups: tannin and non-tannin sorghums. The 
tannin contents in tannin sorghums ranged from 7.0-23.3 mg catechin equivalent (CE)/g 
sample (db), which agreed with Dykes et al. (98) (6.4-50.2 mg CE/g sample). Only 
sorghums with a pigmented testa contain tannins (86, 147). 
Tannin sorghums had varying contents of 3-deoxyanthocyanins (trace to 1.2 mg 
luteolinidin equivalents (LE)/g sample) (Table 1). Among non-tannin sorghums, 3-
deoxyanthocyanin contents in red and black pericarp sorghums ranged from 0.07-4.5 mg 
LE /g sample (db) (Table 1), which was similar to what Awika et al. (103) reported in 
red and black sorghums (0.8-2.8 mg LE/g sample). White and lemon yellow pericarp 
sorghum grains did not contain significant amount of 3-deoxyanthocyanin pigments. 
Pericarp color of sorghum grains is significantly correlated with 3-deoxyanthocyanin 
contents: the darker and redder the grain pericarp color, the higher the 3-
deoxyanthocyanin contents (148, 149). Pericarp color is regulated by the R and Y genes 
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and is not influenced by the presence of tannins (regulated by the dominant B1_B2_ 
gene) (150), which explains why tannin content did not correlate with 3-
deoxyanthocyanin content. 
Total phenol content of tannin sorghums was 5.1 to 29.6 mg gallic acid 
equivalent (GAE)/g sample (db); while non-tannin sorghums ranged from 0.9-18.2 mg 
GAE/g sample (Table 1).  Dykes (109) reported that total phenol contents of tannin 
sorghums was 8-20 mg GAE/g sample and that of non-tannin sorghums was 1.8-6.0 mg 
GAE/g sample. Tannin sorghums generally had higher total phenol content than non-
tannin sorghums (p<0.001) (Figure 4), which agreed with previous reports (109, 151). 
This may be due to the chemistry behind the total phenol assay. The Folin-Ciocalteu 
assay involves redox reaction between phenolate and Folin-Ciocalteu reagent, and the 
assay actually measures a phenol’s reducing capacity (112). Tannins presented in 
sorghum are of condensed type (94, 152, 153) and one condensed tannin molecule can 
have more phenolate groups than one molecule of other phenols, such as phenolic acids, 
flavones, 3-deoxyanthocyanins, and flavanones. This characteristic of condensed tannins 
in tannin sorghums can contribute to their higher total phenol contents than non-tannin 
sorghums. Since the Folin-Ciocalteu method for total phenol content has a similar 
chemical reaction with the single electron transfer reaction based antioxidant capacity 
assays (112), the results of total phenol content indicated that condensed tannins were 
stronger antioxidants than other sorghum phenols.  
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Table 1. Phenolic Content and Free Radical Scavenging Capacity of Sorghum Grains 
 Condensed 
tannins 
(mg CE/g)a 
3-DXA 
content 
(mg LE/g)b 
Phenol content 
(mg GAE/g)c 
ORAC 
(μmol 
TE/g)d 
ABTS 
(μmol 
TE/g)d 
White dent corn nd trace 0.6 ± 0.05 11.8 ± 1.2 7.29 ± 1.3 
ATX635×RTX436 
(white) 
nd trace 0.9 ± 0.09  24.3 ± 3.2 9.70 ± 1.0 
KARI- Mtama (white)  nd trace 8.1 ± 0.3 81.6 ± 1.8 63.9 ±  0.9 
Mizzou White (white) nd trace N. D. N. D. N. D. 
Mizzou (red)  nd  1.0 ± 0.2 11.8 ± 0.6 95.3 ± 1.8 67.4 ±  1.8 
Tx2911 (red) nd 0.27 ± 0.01 3.1 ± 0.1 171 ± 16 44.6 ± 2.0 
98BRON155 (red) nd 0.07 ± 0.01 2.1 ± 0.1 113 ± 14 27.6 ± 1.8 
99LGWO50 (red) trace 0.20 ± 0.01 3.5 ± 0.2 178 ± 17 51.5 ± 1.6 
I CSV III (red) trace 0.14 ± 0.08 7.9 ± 0.1 102 ± 1.1 65.9 ± 0.5 
Tx430 (black)  nd 4.5 ± 0.3 18.2 ± 1.3 126 ± 5.8 78.9 ± 4.3 
SC748 (lemon yellow) nd 0.05 ± 0.01 2.09 ± 0.14 132 ± 18 24.4 ± 2.8 
EBA-3 (lemon yellow) nd 0.03 ± 0.00 2.17 ± 0.11 122 ± 14 25.4 ± 2.5 
Black PI Tall (tannin)  7.2 ± 1.8 1.2 ± 0.07 5.14 ± 0.18 203 ± 31 66.6 ± 4.4 
Cadam (tannin) 18.3 ± 0.4 N. D. N. D. N. D. N. D. 
CR 35 (tannin) 7.0 ± 0.4 trace 16.5 ± 0.5 72.4 ± 6.3 61.6 ± 0.8 
Seredo (tannin)  20.2 ± 0.4 0.7 ± 0.1 21.9 ± 0.4 171 ± 14 118 ± 1.2 
Sumac (tannin)  23.3  ± 1.0 1.2 ± 0.09 29.6 ± 0.7 236 ± 21 125 ± 3.1 
Hi-Tannin (tannin)  18.1 ± 0.6 0.5 ± 0.05 17.6 ± 0.2 182 ± 23 108 ± 4.6 
aCE; catechin equivalents (Vanillin-HCl method). b3-Deoxyanthocyanin pigment content 
expressed as luteolinidin equivalents (LE). cGAE; gallic acid equivalents (Folin-
Ciocalteu method). dTE; trolox equivalents. Values ± sd (db) reported for three separate 
experiments; nd – not detected; N.D. – not determined. 
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Figure 4. Box plot of total phenol contents (mg gallic acid equivalent/g sample) (a), 
ORAC (b) and ABTS (c) antioxidant capacity (μmol Trolox equivalent/g sample) 
between tannin and non-tannin sorghum grains. Tannin sorghum grains had higher total 
phenol content (p<0.001), ORAC value (p<0.006), and ABTS value (p<0.001) than non-
tannin sorghum grains. 
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Antioxidant Capacity of Sorghum Grains 
The antioxidant capacity measured by ABTS assay of tannin sorghum grains 
ranged from 61.6-125 μmol Trolox equivalent (TE)/g sample (Table 1). Dykes (109) 
reported tannin sorghum ABTS antioxidant value ranged from 125-340 μmol TE/g 
sample using 1% HCl acidified methanol as the extraction solvent (ours was 70% 
aqueous acetone). The differences observed in this study could be first due to extraction 
solvent. Another reason can be the different varieties of grains and growth environments 
of the samples, such as year and location. The antioxidant capacity measured by ABTS 
assay of non-tannin sorghum grains ranged from 9.7-78.9 μmol TE/g sample (Table 1), 
which was close to what Dykes (109) reported (8-75 μmol TE/g sample). Tannin 
sorghums had higher antioxidant capacity measured by ABTS assay than non-tannin 
sorghum grains (p<0.001) (Figure 4). Plausible reason for this is that condensed tannins 
are stronger hydrogen donators because of the presence of more phenolate groups in one 
molecule than other phenols (94, 152, 153).  
The antioxidant capacity measured by ORAC assay of tannin sorghum grains 
was 72.4 to 236 μmol TE/g sample (Table 1). Awika et al. (95) reported ORAC 
antioxidant value for tannin sorghum grains as 440-853 μmol TE/g sample using 
aqueous acetone as extraction vehicle. The differences can be due to different varieties 
of tannin sorghums or a different model of instrument used. The antioxidant capacity 
measured by ORAC assay of non-tannin sorghum grains ranged from 24.3 to 178 μmol 
TE/g sample (Table 1), which was close to the ORAC values reported by Awika et. al. 
(95) (21-205 μmol TE/g sample). Similar to ABTS assay, ORAC antioxidant values of 
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tannin sorghum grains were higher than non-tannin sorghum grains (p<0.006) (Figure 4). 
Since ORAC assay measures a competitive reaction between an oxidant and an 
antioxidant, the structure of condensed tannins may make it more efficient in terminating 
the insults from free radicals than other phenols. Besides higher hydrogen donating 
capacity, condensed tannins have a greater metal chelating capacity because of the 
polymerized structures (154). However, some varieties of non-tannin sorghums, e.g. 
99LGWO50 (red), Tx2911 (red), SC748 and EBA-3 (lemon yellow), had ORAC values 
almost as high as tannin sorghums. This suggested that other phenol groups present in 
these varieties, such as flavones and flavanones (109) may have strong free radical 
scavenging capacity as well. 
Antioxidant capacity is an indicator of chemopreventive potential because dietary 
components which are antioxidants can reduce the oxidative stress and terminate the 
insults from free radicals or carcinogens. Hence the antioxidant capacity of these 
sorghum varieties may provide a direct insight into their chemopreventive potential. 
However, antioxidant capacity is not the only factor that influences this potential. It is 
important to determine how gross phenolic profile and antioxidant capacity affect 
chemoprevention by evaluating how the compounds interact with related gastrointestinal 
tract epithelial cells.  
 
Correlation between Gross Phenolic Profile and Antioxidant Capacity 
As previously stated, tannin sorghum grains had higher total phenol content 
(p<0.001), ABTS antioxidant capacity (p<0.001) and ORAC antioxidant capacity 
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(p<0.006) than non-tannin sorghum grains (Figure 4). Total phenol content and ABTS 
antioxidant value correlated with the tannin contents among tested tannin sorghum 
grains (Table 2). Pearson’s correlation determines strength of linear correlation while 
Spearman’s rho (one of nonparametric correlations) evaluates how strong a correlation is 
regardless of its nature. The results suggested that ORAC values of tannin sorghum 
grains were not correlated with their tannin contents significantly. The reason could be 
ORAC assay based on a different chemical reation than total phenol and ABTS assays. 
 
 Table 2. Correlation of Condensed Tannin Content with Total Phenol Content, ABTS 
and ORAC Antioxidant Capacity among Tannin Sorghum Grains 
Correlation coefficient Phenol ABTS ORAC 
Pearson’s correlation Tannins 0.837** 0.995** 0.601 
Spearman’s rho Tannins 0.964** 0.988** 0.600 
** correlation was significant (p<0.01) (2-tailed) 
 
Among non-tannin sorghum grains, content of 3-deoxyanthocyanins (the degree 
of pigmentation) had a strong linear correlation with total phenol content and ABTS 
antioxidant capacity (Table 3). This correlation indicated that 3-deoxyanthocyanin 
content was an indicator of antioxidant capacity in non-tannin sorghum grains. However, 
pigment content in non-tannin sorghum grains only correlated with ORAC antioxidant 
capacity moderately by nonparametric correlation (Spearman’s rho 0.474, p<0.05). This 
suggested that pigmentation itself was not good enough to explain the differences 
observed in ORAC assay. Since the chemical reaction of ORAC assay is quite different 
from total phenol and ABTS assays, it is assumed that other sorghum phenols which are 
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colorless are able to show some free radical scavenging capacity in the ORAC assay. 
The antioxidant capacity of the colorless phenols may be underestimated by ABTS assay 
because they are not strong reducing agents or their reaction with ABTS is slow. Hence 
it is important to consider pigmentation as an indicator of antioxidant capacity but 3-
deoxyanthocyanins are not the only group of antioxidants in non-tannin sorghum grains.  
 
Table 3. Correlation of 3-Deoxyanthocyanin Content with Total Phenol Content, ABTS 
and ORAC Antioxidant Capacity among Non-Tannin Sorghum Grains 
Correlation coefficient Phenol ABTS ORAC 
Pearson’s correlation 3-DXA pigment 0.853** 0.587** 0.109 
Spearman’s rho 3-DXA pigment 0.624** 0.674** 0.474* 
3-DXA: 3-deoxyanthocyanin content  
*   correlation was significant (p<0.05) (2-tailed) 
** correlation was significant (p<0.01) (2-tailed) 
 
 
On the whole, total phenol content of all tested sorghum grains correlated with 
their ABTS antioxidant capacity (Pearson’s correlation 0.911, p<0.001). Since the 
chemical mechanisms of these two assays are similar, the results are expected. Total 
phenol content also correlated with ORAC antioxidant value (Pearson’s correlation 
0.401, p<0.028) but not very strongly, which indicated that reducing potential was not 
the only mechanism for the antioxidant capacity measured by ORAC assay. The ORAC 
assay also measures radical chain-breaking potential of antioxidants (112). The ABTS 
antioxidant capacity had similar moderate correlation with ORAC value (Pearson’s 
correlation 0.599, p<0.001). This may be due to the different chemical principles behind 
these assays.  
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The correlations observed among gross phenolic profiles suggested that certain 
groups of phenols were strong antioxidants, such as condensed tannins and 3-
deoxyanthocyanins. The correlation between phenolic profile and antioxidant capacity 
indicated that phenols in sorghum can serve as indicators as antioxidant capacity. 
 
Gross Phenolic Profiles and Antioxidant Properties of Crude Sorghum Extracts 
Extracts from natural sources, for example, fruits, grains, leaves, roots, can have 
wider applications than the source itself. Because extracts are concentrated and dried, 
they are easier to store, transport, package and use as additives, ingredients, and dietary 
supplements than the bulk original source. Hence it is important to analyze the properties 
of extracts compared with the original material. 
 
Gross Phenolic Profiles of Crude Sorghum Extracts 
Crude sorghum extracts presented similar phenolic profiles compared with 
respective sorghum grains (Table 4). Generally speaking, the extracts were 5- to 30-fold 
higher in condensed tannins, 3-deoxyanthocyanins, and total phenols than the grains.  
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Table 4. Phenolic Content and Free Radical Scavenging Capacity of the Crude Freeze-
Dried Sorghum Extracts 
Extract (grain type) 
Tannins 
(mg 
CE/g)a 
3-DXA (mg 
LE/g)b 
Phenol 
content (mg 
GAE/g)c
ORAC 
(μmol 
TE/g)d 
ABTS 
(μmol 
TE/g)d 
White dent corn nd 0.1 ±0.08 20.4 ± 2.4 776 ± 46 358 ± 31 
ATX635×RTX436 
(white) 
nd 0.3 ± 0.01 24.9 ± 4.3 1232 ± 162 403 ± 37 
KARI-Mtama (white) nd 0.2 ± 0.05 48.3 ± 0.3 1470 ± 97 506 ± 49 
Mizzou White (white) nd 0.4 ± 0.02 26.2 ± 2.1 933 ± 34 276 ± 31 
Mizzou (red) nd 9.7 ± 1.2 81.5 ± 3.2 2050 ± 200 1060 ± 98 
Tx2911 (red) nd 3.8 ± 0.5 88.4 ± 5.2 4758 ± 509 2043 ± 564 
98BRON155 (red) nd 1.0 ± 0.4 49.9 ± 15 4383 ± 690 1261 ± 160 
99LGWO50 (red) trace 4.3 ± 0.5 103 ± 8.7 6284 ± 298 2226 ± 302 
I CSV III (red) trace 4.8 ± 0.4 87.9 ± 8.1 2280 ± 210 1190 ± 140 
Tx430 (black) trace 25.8 ± 2.4 92.2 ± 4.3 2910 ± 210 2790 ± 170 
SC748 (lemon yellow) nd 0.9 ± 0.02 58.5 ± 3.3 3635 ± 365 1405 ± 215 
EBA-3 (lemon yellow) nd 0.8 ± 0.05 66.8 ± 3.5 2822 ± 219 1187 ± 64 
Black PI Tall (tannin) 881 ± 36 18.5 ± 2.5 241 ± 7.5 2958 ± 227 2879 ± 262 
Cadam (tannin) nd 4.0 ± 0.8 45.0 ± 2.5 2944 ± 418 777 ± 46 
CR 35 (tannin) nd 0.9 ± 0.2 69.5 ± 1.6 1670 ± 52 648 ± 13 
Seredo (tannin) 253 ± 10 7.1 ± 2.7 169 ± 7.0 2970 ± 6.0 3310 ± 185 
Sumac (tannin) 394  ± 15 16.3 ± 8.1 308 ± 13 6333 ± 697 4420 ± 270 
Hi-Tannin (tannin) 605 ± 23 5.3 ± 0.5 251 ± 14 2630 ± 190 4320 ± 420 
aCE; catechin equivalents (Vanillin-HCl method). b3-Deoxyanthocyanin pigment 
content expressed as luteolinidin equivalents. cGAE; gallic acid equivalents (Folin-
Ciocalteu method). dTE; trolox equivalents (antioxidant activity). Values ± sd reported 
three separate experiments; nd – not detected. 
 
 
Condensed tannin content in tannin sorghum extracts varied vastly: the crude 
extracts from Cadam and CR35 did not contain detectable condensed tannins; the rest of 
the crude tannin sorghum extracts had 253-881 mg CE/g sample. The difference should 
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be from the genetics of tannin sorghums. According to the presence of a spreader gene 
SS, tannin sorghums can be divided into two groups, type II sorghum (recessive spreader 
gene) and type III sorghum (with spreader gene) (155). The extractability of condensed 
tannins in these two groups is different: tannins in type II sorghum can only be extracted 
with acidified methanol because acid is needed to disturb the structure of the vesicles in 
the pigmented testa where tannins are located (156). The extraction solvent used to 
obtain the extracts was 70% aqueous acetone; hence condensed tannins in Cadam and 
CR35 were not extracted in corresponding freeze-dried extracts. So Cadam and CR35 
crude extracts were grouped into non-tannin sorghum extracts within the discussion 
here. 
3-Deoxyanthocyanin contents in crude sorghum extracts followed similar trends 
as the grains (Tables 1 & 4). Tannin sorghum extracts contained varying amounts of 3-
deoxyanthocyanins (5.3-18.5 mg LE/g sample) because pigment and condensed tannin 
contents are controlled by different genes (150). Red and black pericarp sorghum 
extracts contained high levels of 3-deoxyanthocyanins, for example, Tx430 (black) (25.8 
mg LE/g), Black PI Tall (tannin) (18.5 mg LE/g), and Mizzou (red) (9.7 mg LE/g). 
White and lemon yellow pericarp sorghum extracts contained low levels of 3-
deoxyanthocyanins (less than 1 mg LE/g sample). Dark red pericarp color of sorghum 
grains is associated with higher 3-deoxyanthocyanin contents in the crude extracts. 
Total phenol content in tannin containing sorghum extracts (169-308 mg GAE/ g 
sample) was higher than non-tannin containing extracts (24.9-103 mg GAE/ g sample) 
(p<0.001) (Figure 5). Based on the total phenol contents of crude sorghum extracts, the 
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antioxidant capacity of crude sorghum extracts were expected to have similar trends as 
the grains. 
The phenolic profile in extracts from different natural sources varies depending 
on the source and extraction solvent. Yang et al. (157) reported that total phenolics of 
80% aqueous acetone extracts from common edible nuts ranged from 1.5-15.8 mg 
GAE/g extract. Chen and Blumberg (158) used both acidified methanol and 
gastrointestinal juice mimics to extract the phenols from almond skin. They found the 
total phenol content of the extracts was 15.5 mg and 2.5 mg GAE/g for the two methods, 
respectively. Ajila and others (159) reported the total phenols from 80% acetone extracts 
of mango peel was 54.7-109.7 mg GAE/g extract. Dai and others (160) extracted Hull 
blackberry with acidified ethanol and reported total phenol content was 17.3 mg GAE/g 
dried extract. Compared with these studies, sorghum grains have higher total phenols, 
which indicate potential to use sorghum extracts in the functional food industry.  
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Figure 5.  Box plot of total phenol contents (mg gallic acid equivalent/g sample) (a), 
ORAC (b) and ABTS (c) antioxidant capacity (μmol Trolox equivalent/g sample) 
between crude tannin and non-tannin sorghum extracts. Crude sorghum extracts 
containing tannin had higher total phenol (p<0.001) and ABTS (p<0.001) antioxidant 
capacity than crude sorghum extracts which do not contain tannins, but the difference 
between ORAC values was not significant (p<0.194). 
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Antioxidant Capacity of Crude Sorghum Extracts 
The antioxidant capacity of crude sorghum extracts was 10 to 40 times higher 
than that of their grains. The antioxidant capacity measured by ABTS assay of tannin 
containing extracts ranged from 2879-4420 μmol TE/g sample; while non-tannin 
containing extracts ranged from 276-2790 μmol TE/g sample (Table 4). The trend was 
generally related to what was observed in sorghum grains.  
 The antioxidant capacity measured by ORAC assay of tannin containing extracts 
was from 2630 to 6333 μmol TE/ g sample; while non-tannin containing extracts varied 
from 933- 6284 μmol TE/ g sample (Table 4). The difference in ORAC values (p<0.194) 
between tannin containing and non-tannin containing crude sorghum extracts was not 
significant as total phenol content and ABTS antioxidant capacity (p<0.001). The 
possible reason was some other groups of phenol in non-tannin containing crude extracts 
were more efficient in the kinetic experimental settings using ORAC to evaluate 
antioxidant capacity. For example, the crude extract from 99LGWO50, a red thick 
pericarp sorghum with tan secondary plant color (109), showed ORAC value of 6284 
μmol TE/g sample, which is almost as high as Sumac (tannin) extracts (6333 μmol TE/g 
sample). Also, crude extracts from Tx2911, 98BRON155, SC748 all showed relatively 
high ORAC values among non-tannin extracts, which was higher than the crude extract 
from Tx430 (black). This indicated that pigmentation alone can not explain the higher 
ORAC values in these crude sorghum extracts. Dykes (109) observed similar high 
antioxidant capacity trends among these sorghum grains. Further investigation into the 
phenolic profile found that flavanones, flavan-4-ols, and flavones content in 
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99LGWO50, Tx2911, 98BRON155, and SC748 sorghum grains were relatively high 
(109). Aqueous acetone extraction may concentrate these groups of phenols in the 
freeze-dried extracts. 
Many studies report the antioxidant potential of extracts from different plant 
sources using varying methods; hence it is difficult to compare the antioxidant capacity 
values reported in literature. Yang et al. (157) reported that the antioxidant capacity of 
phenolic extracts from common nuts measured by Total Oxyradical Scavenging 
Capacity assay, which is similar to ORAC assay, ranged from 7.1-458.1 μmol vitamin C 
equivalent/g. Chen and Blumberg (158) reported that ORAC value of almond skin 
extract was around 3.0 μmol Trolox equivalent/ μmol GAE. Dai and others (160) 
determined the antioxidant capacity of dried blackberry extract using ABTS was around 
67.0 μmol TE/g extract. By a rough comparison with similar studies, crude extracts from 
different sorghum grains exhibited relatively strong antioxidant potential. This 
characteristic makes crude sorghum extracts potent source of healthy food ingredients or 
dietary supplements. 
 
Correlation between Gross Phenolic Profile and Antioxidant Capacity 
 Tannin content of crude sorghum extracts did not correlate with total phenol 
content, or ABTS or ORAC antioxidant capacity of crude tannin extracts (Table 5) 
though the correlation of tannin content was observed in tannin sorghum grains (Table 
2). The results suggested that after 70% acetone extraction, removal of acetone, and 
freeze-drying, the phenolic profile of crude sorghum extracts was different than the 
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sorghum grains. Some phenols may be concentrated, and some may be lost during this 
process. Hence the impact of condensed tannins was not as great as it was in sorghum 
grains. Another possibility was small sample size. We only have 4 varieties of tannin 
sorghum included in this correlation. There may be a correlation if we could include 
more varieties. 
 
Table 5. Correlation of Condensed Tannin Content with Phenol Content, ABTS, and 
ORAC Antioxidant Capacity among Crude Tannin Sorghum Extracts. 
Correlation coefficient Phenol ABTS ORAC 
Pearson’s correlation Tannins 0.258 -0.302 -0.319 
Spearman’s rho Tannins 0.310 -0.048 -0.238 
                      
 
 
 
Among crude non-tannin extracts, 3-deoxyanthocyanin content correlated with 
total phenol content, ABTS, and ORAC antioxidant capacity significantly (ORAC only 
significant for Spearman’s rho correlation, Table 6). This correlation suggested that 3-
deoxyanthocyanins were a major contributor to antioxidant capacity in the extracts. 
However, as mentioned above, some red pericarp sorghum (99LGWO50, Tx2911, and 
98 BRON155) and lemon yellow pericarp sorghum contained other colorless phenols 
that also had strong antioxidant capacity.  
 
 
Table 6. Correlation of 3-Deoxyanthocyanin Content with Phenol Content, ABTS, and 
ORAC Antioxidant Capacity among Crude Non-Tannin Sorghum Extracts. 
Correlation coefficient Phenol ABTS ORAC 
Pearson’s correlation 3-DXA pigments 0.519** 0.677** 0.098 
Spearman’s rho 3-DXA pigments 0.785** 0.703** 0.502** 
              ** correlation was significant (p<0.01) (2-tailed) 
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 Overall, the total phenol content of all the crude sorghum extracts correlated 
significantly with ABTS and ORAC antioxidant capacity (Pearson’s correlation 0.911, 
p< 0.001 and 0.451, p< 0.007, respectively). The correlation suggested that phenols were 
the major components in the extracts that had antioxidant potential. Also, the two 
antioxidant assays correlated with each other (Pearson’s correlation 0.570, p< 0.001), 
which indicated that though the chemical basis is different in these two assays, the 
results reflected similar antioxidant potential of the crude extracts. 
 Based on the gross phenolic profile and antioxidant capacity of these seventeen 
sorghums, different genotypes presented varying phenolic profiles. The presence and 
amount of condensed tannins and 3-deoxyanthocyanins had major impact on antioxidant 
levels. Thus we studied how these two groups of compounds affect chemopreventive 
potential of sorghums. Capacity to scavenge free radicals such as ROS/RNS and 
carcinogens could minimize the oxidative damage to normal cells and reduce oxidative 
stress in the body (21). Hence sorghum varieties representing varying levels of 3-
deoxyanthocyanins and condensed tannins were selected to further investigate how 
composition of sorghum affects chemoprevetive potential on relevant cancer cells.    
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CHAPTER V 
PHASE II ENZYME INDUCING AND ANTIPROLIFERATIVE POTENTIAL OF 
CRUDE SORGHUM EXTRACTS 
 
NAD(P)H:Quinone Oxidoreductase (QR) Inducing Capacity of Crude Sorghum 
Extracts 
Capacity of dietary phytochemicals to elevate the activity of phase II detoxifying 
enzymes in normal cells is an important cancer initiation blocking mechanism (45). The 
phase II enzyme inducing capacity of crude sorghum extracts should be a useful 
screening tool for determining chemopreventive potential of sorghum. 
Nine sorghum varieties were used to measure the NAD(P)H:quinone 
oxidoreductase (QR) inducing potencial. Four non-tannin sorghums were selected based 
on pericarp pigmentation: KARI-Mtama (white), Mizzou (red), I CSV III (red) and 
Tx430 (black). Five tannin sorghums included two type II tannin sorghum, Cadam and 
CR35; and three type III sorghum, Seredo, Sumac and Hi-Tannin. Because Hepa 1c1c7 
cell growth was affected by the crude sorghum extracts, QR specific inducer ratio which 
was corrected for cell population was reported. 
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Figure 6. Effect of crude non-tannin sorghum extracts on (a) Hepa 1c1c7 murine 
hepatoma cells growth and (b) NAD(P)H:quinone oxidoreductase (QR) specific inducer 
ratio (after correction for cell population). Cells (10,000/well) were induced with 
extracts for 24 h before QR activity analysis. Legend represents concentrations (μg/mL) 
of crude sorghum extracts used while concentrations of Tx430 (black) are shown in 
parentheses.  Error bars represent ± sd from two separate experiments. * indicates 
significantly different QR inducer ratio from that in control cells (p < 0.05, Dunnett’s 
multiple comparison, 2-sided).  
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All the tested crude non-tannin sorghum extracts showed a quadratic except 
KARI-Mtama (white) showed a dose-dependent QR inducing capacity (Figure 6). Tx430 
(black) had the highest QR specific inducer ratio among the four varieties; it doubled QR 
activity at 25 μg/mL and maximally increased QR activity 2.7-fold at 100 μg/mL. Tx430 
(black) did not show significant inhibition of Hepa 1c1c7 growth at the concentrations 
tested, which indicated that the QR activity induced by Tx430 (black) was independent 
of change in cell population. The Tx430 (black) extract contained the highest 3-
deoxyanthocyanin contents (25.8 mg luteolinidin equivalent (LE)/ g of extract, Table 4) 
among all non-tannin sorghum extracts, which may partly explain its high QR inducing 
capacity.  
Two red varieties (Mizzou and I CSV III) showed similar QR specific inducer 
ratio. Mizzou (red) maximized QR activity by 50% at 200 μg/mL; while I CSV III (red) 
increased QR activity by 60% at 200 μg/mL. Mizzou (red) and I CSV III (red) extracts 
contained less 3-deoxyanthocyanin content than Tx430 (black) (9.6 and 4.8 mg LE/g, 
respectively). The difference in 3-deoxyanthocyanin contents could partly explain the 
different QR inducing potency. However composition of 3-deoxyanthocyanins and other 
flavonoids may also affect QR inducing potential in pigmented sorghum varieties.  
Crude extract of white pericarp sorghum KARI-Mtama showed higher QR 
inducing potential than both red varieties; it increased QR activity by almost 60% at the 
concentration of 200 μg/mL and almost doubled QR activity at 400 μg/mL. This 
indicated that non-pigmented phenols in white sorghum likely induced QR activity in 
Hepa 1c1c7 cells.  
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The QR specific inducer ratio of five tannin sorghum is shown in Figure 7. The 
five tannin sorghum crude extracts did not show any QR activity inducing potential. 
Cadam increased QR activity by 20% maximally at 10 μg/mL but this was not 
statistically significant; while CR35 increased QR activity by 40% maximally at 50 
μg/mL. Crude extracts from Cadam and CR35 did not contain detectable condensed 
tannins. Hence it is possible that other phenols which are also present in non-tannin 
sorghums were able to induce QR activity. Seredo and Sumac extracts did not increase 
any significant QR activity at concentrations tested; Hi-Tannin extracts exhibited a 
significant 20-30% QR activity increase at lowest concentration (1 and 5 μg/mL) but the 
QR activity decreased when concentration went up. An inhibitory effect of tannin 
containing sorghum extracts on Hepa 1c1c7 cells was observed when concentration was 
greater than 20 μg/mL. This may partly explain why QR inducing potential was not seen 
in these three varieties. Another possibility is that condensed tannins can not induce QR 
activity or are inhibitors of QR activity. 
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Figure 7. Effect of crude tannin sorghum extracts on (a) Hepa 1c1c7 murine hepatoma 
cells growth and (b) NAD(P)H:quinone oxidoreductase (QR) specific inducer ratio (after 
correction for cell population). Cells (10,000/well) were induced with extracts for 24 h 
before QR activity analysis. Legend represents concentrations (μg/mL) of crude tannin 
sorghum extracts used.  Error bars represent ± sd from two separate experiments. * 
indicates significantly different QR inducer ratio than that in control cells (p < 0.05, 
Dunnett’s multiple comparison, 2-sided). 
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Among the nine sorghum varieties tested, QR specific inducer ratio varied 
according to their compositions: condensed tannins containing crude sorghum extracts 
were non-inducers. Among non-tannin sorghum crude extracts, Tx430 (black), a black 
pericarp sorghum containing the highest level of 3-deoxyanthocyanins, was the most 
potent QR inducer; red pericarp sorghum crude extracts were less efficient QR inducers; 
the QR inducing potential of white sorghum was better than the red ones but not better 
than the black variety. However, taking all the sorghum varieties into account, there was 
no correlation between QR inducing potential and total phenol content or antioxidant 
capacity of the crude sorghum extracts. Condensed tannin containing crude extracts had 
higher total phenol content and antioxidant capacity but no QR inducing potencial; white 
sorghum extracts contained less total phenols with less antioxidant capacity but showed 
a moderate QR inducing capacity.  
Yang and Liu (161) reported that acetone extracts from different varieties of 
fresh grapes were potent QR inducers with QR activity doubling concentration of 600-
800 μg/mL using Hepa 1c1c7 cells. Similarly, the authors suggested that there was no 
positive correlation found between QR induction and antioxidant capacity of these 
varieties of grapes. Additionally, some white varieties of grapes had higher QR 
induction potential than red varieties, which indicated that pigmentation of grapes was 
not correlated with QR inducing potential. Chen and Blumberg (158) used acidified 
methanol and gastrointestinal juice mimics extracted almond skin extracts to induce QR 
in Hepa 1c1c7 cells and found the two extracts behaved differently: acidified methanol 
extract was a QR inducer while gastrointestinal juice extract was QR inhibitor. 
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Srivastava et al. (162) did not find any phase II enzyme inducing potential from 
anthocyanin fractions of blueberry extracts. This indicated that activation of the cellular 
upregulation of phase II enzymes does not necessarily relate to higher antioxidant 
capacity but is more dependent on structure, steric bulk and partition coefficient 
(lipophilicity) (163) of a compound.  
Sorghum is a rich source of different groups of phenolic compounds. It is 
apparent that different groups of phenols have different effects on phase II enzymes. 
Hence it is beneficial to determine the effect of different fractions of sorghum phenols 
on phase II enzyme inducing potential, such as 3-deoxyanthocyanins, flavones and 
flavanones, to obtain a complete picture for how phenolic profiles of various sorghum 
varieties may affect phase II enzyme inducing potential.  
 
Inhibitory Effect of Sorghum Crude Extracts on Human Colon and Esophageal 
Carcinoma Cell Proliferation 
The capacity to inhibit cancer cell proliferation is an important aspect of 
chemoprevention (45). Seven crude sorghum extracts were selected: three condensed 
tannin containing crude extracts from tannin sorghums, Seredo, Sumac and Hi-Tannin; 
four crude extracts from non-tannin sorghums, KARI-Mtama (white), Mizzou White 
(white), Mizzou (red) and Tx430 (black). The two assays used in this study (MTT and 
PicoGreen assay) generally showed the same inhibitory trends for the extracts tested. 
However, we noticed that MTT assay consistently estimated higher viable cell 
population than the PicoGreen assay in preliminary tests. We suspected this was because 
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of the interference of the phenols present in the extracts. MTT assay is based on the 
ability of a mitochondrial dehydrogenase enzyme from viable cells to cleave the 
tetrazolium rings of the pale yellow MTT and form a dark blue formazan crystals. The 
number of surviving cells is directly proportional to the level of the formazan product 
created (129). However, phenols in sorghum may reduce MTT and form the dark blue 
color without the presence of viable cells. The color interference due to the extracts 
resulted in higher false reading. Blank sample using only the extracts were used to 
correct for the interference from phenols. 
The inhibitory effect of the seven selected crude sorghum extracts generally 
followed a dose-response pattern but with different inhibitory endpoints (Figure 8 & 9). 
The inhibitory pattern of these extracts on both human colon cancer (HT-29) and 
esophageal cancer (OE33) cell lines was similar. In order to further compare the 
inhibitory effect of sorghum extracts, IC50s (Table 7), a parameter estimates the 
concentration for a compound needed to inhibit 50% of cancer cell proliferation, were 
calculated. A lower IC50 indicated a stronger inhibitory capacity.  
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Figure 8. Inhibition of HT-29 human colon carcinoma cell proliferation by crude 
sorghum extracts (baseline to 0.1% DMSO) measured by MTT (top) and PicoGreen 
(bottom) assays. Cells (2000/well) were induced with extracts for 48h before 
proliferation assay. Error bars represent standard deviation from triplicates. 
  
69
 
Figure 9. Inhibition of OE33 human lower esophageal adenocarcinoma cell proliferation 
by crude sorghum extracts (baseline to 0.1% DMSO) measured by MTT (top) and 
PicoGreen (bottom) assays. Cells (2000/well) were induced with extracts for 48h before 
proliferation assay. Error bars represent standard deviation from triplicates. 
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Table 7.  Concentration (μg/mL) of Crude Sorghum Extracts Needed to Inhibit 50% of 
HT-29 (colon) and OE33 (lower esophageal) Carcinoma Cell Proliferation (IC50) 
 IC50 (μg/mL) 
Sample HT-29 OE33 
(type) MTT PicoGreen MTT PicoGreen 
KARI-Mtama 
(white) 452 ± 111 
b 635 ± 180 b 824 ± 204 b 883 ± 13.8 d 
Mizzou White 
(white) 608 ± 108 
b 611 ± 19.8 b 701 ± 44.3 a,b 747 ± 57.1 c 
Mizzou  
(red) 190 ± 0.3 
a 262 ± 50.1 a 604 ± 57.8 a,b 553 ± 18.4 b 
Tx430  
(black) 164 ± 22.9 
a 141 ± 10.9 a 458 ± 58.9 a 208 ± 7.3 a 
Overall mean 
(non-tannin) 354 412 647 598 
Seredo  
(tannin) 85.0 ± 4.7 
a 99.0 ± 1.4 b 131 ± 1.9 b 88.0 ± 1.6 b 
Sumac  
(tannin) 95.6 ± 10.3 
a 59.1 ± 18.6 a,b 91.9 ± 6.6 a 51.9 ± 2.4 a,b 
Hi-Tannin 
(tannin) 130 ± 3.0 
b 50.6 ± 3.3 a 125 ± 13 b 49.7 ± 11.4 a 
Overall mean 
(tannin) 104 69.6 118 63.1 
Cells (2000/well) were induced with extracts for 48h before proliferation assay. Values ± 
sd (μg/mL) reported from three separate experiments. Tannin sorghum extracts had 
significantly lower IC50s than non-tannin sorghum extracts (p<0.05). Within tannin and 
non-tannin sorghum extract groups, values with different letters within the same column 
were different (Fisher’s LSD, p<0.05). 
 
 
 
 
Tannin sorghum extracts inhibited almost 80% of both HT-29 and OE33 growth 
at around 200 μg/mL and reached 90-95% inhibition at 800 μg/mL. The IC50s of tannin 
sorghum extracts for HT-29 ranged from 50.6-130 μg/mL and 49.7-131 μg/mL for 
OE33. Though the condensed tannin content in these three extracts differed from each 
other (Table 4), the inhibitory effect was generally similar. The black sorghum Tx430 
showed the strongest inhibition potential among the three non-tannin sorghums, with 
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IC50s of 141-458 μg/mL (though statistical analysis was not significant on all assays). It 
inhibited HT-29 growth by more than 90% at 800 μg/mL, which was similar endpoint 
inhibition as the tannin sorghum extracts; it inhibited approximately 70% of OE33 
growth at 800 μg/mL. The Mizzou (red) had IC50s from 190-604 μg/mL, and it achieved 
maximal inhibition of HT-29 (about 65% inhibition) and OE33 (about 55% inhibition) 
growth at 800 μg/mL. The two white varieties KARI-Mtama and Mizzou White had 
similar IC50s from 452 to 883 μg/mL. Both of them achieved 60% inhibition against HT-
29 growth at 800 μg/mL and around 46% inhibition of OE33 proliferation at the same 
concentration. 
Tannin sorghum extracts were stronger GIT cancer cell proliferation inhibitors 
than non-tannin sorghum extracts. For both MTT and PicoGreen assays, crude tannin 
sorghum extracts had significantly lower IC50s than crude non-tannin sorghum extracts 
(p<0.05) (Figure 10). Condensed tannins present in sorghum were probably responsible 
for the higher cancer cell proliferation inhibition. McDougall and others (164) 
determined the antiproliferative capacity of anthocyanin-rich and tannin-rich fractions of 
lingonberry extracts and concluded that tannin-rich fraction had a stronger inhibitory 
potential than anthocyanin-rich fraction.  
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Figure 10. Box plot of IC50s (μg/mL) (concentration needed to inhibit 50% of cell 
growth) of crude tannin and non-tannin sorghum extracts, (a) IC50s on HT-29 
proliferation measured by MTT assay; (b) IC50s on HT-29 proliferation measured by 
PicoGreen assay; (c) IC50s on OE33 proliferation measured by MTT assay; (d) IC50s on 
OE33 proliferation measured by PicoGreen assay. Crude tannin sorghum extracts had 
lower IC50s than crude non-tannin sorghum extracts (all p-values < 0.05). 
 
 
Due to the stronger inhibition observed in Tx430 (black) and Mizzou (red) 
extracts among non-tannin sorghum extracts, 3-deoxyanthocyanins may have 
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contributed to the inhibitory potential among non-tannin pigmented sorghum varieties. 
Shih et al. (19) indicated aglycones of 3-deoxyanthocyanins, apigeninidin and 
luteolinidin,  had stronger antiproliferative capacity than their anthocyanidin analogs. 
Additionally, non-pigmented sorghum flavonoids could have inhibitory effect against 
GIT cancer cell growth based on the inhibitory capacity observed in white sorghum 
extracts.  
Overall, all sorghum extracts tested had relative strong inhibition capacity against 
HT-29 growth (IC50s 50.6-635 μg/mL) than other natural phenol extracts reported in 
literature. Yi et al. (165) observed that crude extracts from various muscadine grapes had 
IC50s of 1000-7000 μg/mL (48 h incubation) against HT-29 growth measured by MTT 
assay. Netzel and others (166) reported that anthocyanin fraction from black carrots had 
an IC50 greater than 1000 μg/mL (48 h incubation) against HT-29 growth using MTT 
assay. This suggests that compounds in sorghum extracts may have stronger cancer 
growth inhibitory potency than those found in other resources, which agrees with Shih et 
al. (19). 
The antiproliferative effect of sorghum extracts was correlated with phenolic 
profiles and antioxidant properties. The IC50s had a negative correlation with ABTS 
values (Pearson’s correlation 0.778-0.941), total phenol content (Spearman’s rho 0.844-
0.944) and ORAC values of the crude extracts (Spearman’s rho 0.713-0.867) (p all less 
than 0.05) (Table 8). Yang et al. (157) determined the antiproliferative capacity of crude 
extracts from nuts and concluded that inhibitory potency was correlated with phenolics 
and flavanoids contents as well as total antioxidant capacity of the extracts. By this 
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token, we can use phenol content and antioxidant capacity of a crude sorghum extract as 
an indicator of its antiproliferative potential. However, the correlation between 
antiproliferation and antioxidant potential of crude extract can be misleading because 
different groups of phenols may have different impact on antioxidant potential. For 
example, tannins are stronger hydrogen donators (94, 152, 153), but tannin content itself 
did not correlate with the antioxidant capacity of crude tannin extracts (Table 5). So 
phenolic composition should be considered when correlate phenol content and 
antioxidant potential, further when correlate antioxidant and antiproliferation potential. 
Thus we may only conclude that phenol composition affects GIT cancer growth by this 
correlation. 
 
 
Table 8. Correlation between IC50s and Chemical Properties of Crude Sorghum Extracts 
 
Correlation coefficient 
IC50 (μg/mL) 
HT-29 OE33 
MTT PicoGreen MTT PicoGreen
Pearson’s 
Correlation 
ABTS -0.778** -0.839** -0.904** -0.941** 
ORAC -0.666* -0.652* -0.759** -0.709** 
Phenol content -0.659* -0.705* -0.849** -0.791** 
Spearman’s 
rho 
ABTS -0.820** -0.944** -0.860** -0.965** 
ORAC -0.841** -0.713** -0.867** -0.727** 
Phenol content -0.844** -0.937** -0.923** -0.944** 
     *correlation is significant at the 0.05 level (2-tailed). 
     **correlation is significant at the 0.01 level (2-tailed).  
 
 
  
75
For sorghum, separation of the crude extract into different phenol fractions 
would determine the role of each group of phenol in chemoprevention. Identification of 
the specific active components is also needed to determine how structure of these 
components affects the chemopreventive capacity. Based on this information, 
mechanisms involved in chemoprevention of sorghum phenols would be determined, i.e. 
mechanisms for inducing phase II enzymes; mechanisms for inhibit cancer cell 
proliferation, to see if apoptosis is induced or cell cycle is arrested. This will open up 
opportunities to utilize sorghum as a rich and economical source of ingredients for 
health-related industries.  
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CHAPTER VI 
EFFECT OF 3-DEOXYANTHOCYANIDIN STRUCTURE ON PHASE II 
ENZYME INDUCING AND ANTIPROLIFERATIVE POTENTIAL 
 
Uda et al. (167) reported that among natural flavonoids, structure had an impact 
on the capacity to induce phase II enzyme, NAD(P)H: quinone oxidoreductase (QR). 
They suggested a 2-3 double bond on the C-ring was essential to induce QR; i.e. 
catechin was not QR inducer but apigenin was. Shih et al. (19) reported that aglycones of 
3-deoxyanthocyanins exhibited stronger antiproliferative capacity than their 
anthocyanidin analogs. Additionally, relatively strong QR inducer and antiproliferative 
potential of crude extract from Tx430 (black) sorghum made it essential to determine 
effect of structure on the chemopreventive potential of the unique 3-deoxyanthocyanins. 
Hence two groups of major sorghum 3-deoxyanthocyanin aglycones, apigeninidin and 
luteolinidin and their methoxylated derivatives, were used to determine the effect of 3-
deoxyanthocyanidin structure on their QR inducing and human colon and esophageal 
cancer cell proliferation inhibition capacity.  
 
Effect of 3-Deoxyanthocyanidin Structure on Antioxidant Capacity 
The antioxidant capacity of 3-deoxyanthocyanidins is shown in Table 9.  No 
meaningful correlation between structure and ABTS values was observed. The possible 
reason is antioxidant capacity of individual molecules is affected by various reaction 
factors, such as solvent system, reaction time, probes, protocols, etc. As to ORAC 
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values, methoxylation reduced ORAC antioxidant capacity for both apigeninidin and 
luteolinidin.  
 
Table 9.  Free Radical Scavenging (Antioxidant) Capacity of 3-Deoxyanthocyanidins. 
Results Were Expressed as mol Trolox Equivalent (TE)/ mol Sample.   
Mean ± Standard deviation was reported from three separate replicates. Within columns, 
values with different letters are different, p<0.05 (Turkey’s HSD). 
 
 
It has been reported that structure has an important impact on antioxidant 
capacity of flavonoids. Hydroxylation, especially ortho-(3’,4’-) dihydroxyl group on the 
B-ring, enhances free radical scavenging capacity and metal chelating capacity (154, 
168, 169). On the other hand, hydroxylation or methoxylation on the A-ring could 
decrease or increase antioxidant capacity (154, 168, 169). Our study found that 
methoxylated luteolinidin and apigeninidin derivatives generaly had lower antioxidant 
capacity than non-methoxylated aglycones. We also observed that ORAC assay 
measured a bigger difference between apigeninidin/luteolinidin and their methoxylated 
derivatives than ABTS assay. The different chemical principle of the two assays may 
contribute to this difference observed. More 3-deoxyanthocyanins standards are needed 
  
ORAC  
(mol TE/ mol sample) 
ABTS 
(mol TE/ mol sample) 
Apigeninidin 7.4 ± 0.7 a 4.0 ± 0.2 a,b,c 
7-Methoxyapigeninidin 4.7 ± 0.9 a,b 3.7 ± 0.1 b,c 
5-Methoxyapigeninidin 2.9 ± 0.4 b 2.6 ± 0.02 d 
5,7-Dimethoxyapigeninidin 2.9 ± 1.0 b 3.6 ± 0.1 c 
Luteolinidin 7.6 ± 1.0 a 4.3 ± 0.1 a,b 
5,7-Dimethoxyluteolinidin 4.4 ± 0.6 a,b 4.6 ± 0.1 a 
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in order to determine the effect of different substitution pattern on their antioxidant 
capacity.  
 
Effect of 3-Deoxyanthocyanidin Structure on NAD(P)H:Quinone Oxidoreductase 
(QR) Inducing Capacity 
The QR specific inducer ratios of apigeninidin and its derivatives are shown in 
Figure 11. Apigeninidin doubled QR activity at 20 μM, which was also its maximal 
inducer ratio. 7-Methoxyapigeninidin showed higher maximal QR inducing potential, 
almost 2.7-fold increase at 50 μM. 5-Methoxyapigeninidin maximally increased QR 
activity by 70% at 50 μM. 5,7-Dimethoxyapigeninidin had the strongest inducing 
potency among apigeninidin derivatives: doubled the QR activity at 0.2 μM; and 
increased to 3-fold at 5 μM.  
The QR inducer ratio of luteolinidin and its derivatives are shown in Figure 12. 
Luteolinidin did not show significant increase of induced QR activity at tested 
concentrations. 5,7-Dimethoxyluteolinidin on the other hand increased QR activity by 
2.4-fold at 50 μM and maximally 4.2-fold at 100 μM. We noticed some pure compounds 
used in this study, besides 5,7-dimethoxyluteolinidin, 7-methoxyapigeninidin, 
sulforaphane and genistein, inhibited Hepa 1c1c7 growth at most concentrations tested. 
It suggested that the upregulated QR activity may be due to the potency of those 
compounds or the stress from inhibition of proliferation. The QR activity can be induced 
in response of xenobiotics, antioxidants, oxidants, heavy metals, UV, light, stress 
conditions and ionizing radiation (170-172), and its activity is also upregulated in 
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malignant tissues (170). Hence the upregulated QR activity observed in this study may 
come from the effect of inhibited proliferation, not merely the direct inducing potency of 
the compound. Sulforaphane, the known QR inducer isolated from broccoli, doubled the 
QR activity between 0.2-0.5 μM and had a maximal QR activity increase of 4.2-fold at 
10 μM (Figure 13), which confirmed to Prochaska’s findings (123). Genistein, the 
isoflavone isolated from soybean, doubled QR activity at 10 μM and had a maximal QR 
specific inducer ratio of 3.7 at 50 μM (Figure 13), which agreed with what Yang and Liu 
reported (161).  
The dimethoxylated forms of 3-deoxyanthocyanin aglycones had equivalent 
maximal QR specific inducer ratio as sulforaphane and genistein tested under the same 
experimental conditions. Gao and others (124) reported that nitric oxide-donating 
aspirin, the most extensively studied nitric oxide-donating non-steroidal anti-
inflammatory drug, increased QR activity by 2.3-fold maximally at 100 μM. Yang and 
Liu (161) reported only quercetin and resveratrol exhibited QR inducing capacity among 
common grape flavonoids, with maximal 3.5-fold increase at 30 μM and 2.2- fold at 50 
μM, respectively. This suggested that dimethoxylated apigeninidin and luteolinidin have 
strong potential as chemopreventive agents. 
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Figure 11. Effect of apigeninidin and its derivatives on (a) Hepa 1c1c7 murine hepatoma 
cells growth and (b) NAD(P)H:quinone oxidoreductase (QR) specific inducer ratio (after 
correction of cell population). Cells (10,000/well) were induced with extracts for 24 h 
before QR activity analysis. Legend represents concentrations (μM) used while 
concentrations of 5,7-dimethoxyapigeninidin are shown in parentheses.  Error bars 
represent ± sd from two separate experiments. * indicates significantly different QR 
inducer ratio than that in control cells (p < 0.05, Dunnett’s multiple comparison, 2-
sided). 
  
81
Figure 12. Effect of luteolinidin and 5,7-dimethoxyluteolinidin on (a) Hepa 1c1c7 
murine hepatoma cells growth and (b) NAD(P)H:quinone oxidoreductase (QR) specific 
inducer ratio (after correction of cell population). Cells (10,000/well) were induced with 
extracts for 24 h before QR activity analysis. Legend represents concentrations (μM) 
used while concentrations of 5,7-dimethoxyluteolinidin are shown in parentheses.  Error 
bars represent ± sd from two separate experiments. * indicates significantly different QR 
inducer ratio than that in control cells (p < 0.05, Dunnett’s multiple comparison, 2-
sided). 
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Figure 13. Effect of sulforaphane and genistein on (a) Hepa 1c1c7 murine hepatoma 
cells growth and (b) NAD(P)H:quinone oxidoreductase (QR) specific inducer ratio (after 
correction of cell population). Cells (10,000/well) were induced with extracts for 24 h 
before QR activity analysis. Legend represents concentrations (μM) used while 
concentrations of genistein are shown in parentheses.  Error bars represent ± sd from two 
separate experiments. * indicates significantly different QR inducer ratio than that in 
control cells (p < 0.05, Dunnett’s multiple comparison, 2-sided). 
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The findings indicated a structure-activity relationship of QR inducing capacity 
of 3-deoxyanthocyanidins: methoxylation of the A-ring improved QR inducing capacity; 
position of methoxylation (like 7- or 5- on the A-ring) also influenced it. The results 
confirmed that the efficacy of a compound to induce phase II enzyme does not 
necessarily relate to its antioxidant capacity. The structure of the compound probably 
plays a more important role. Uda et al. (167) suggested that a double bond at the 2-3 
position of the C-ring was essential for a flavonoid to induce QR activity and 
hydroxylation of the B-ring was not essential. Harris et al. (163) proposed that 
bioactivity of phenolics correlated with steric bulk (structural configuration) as well as 
lipophilicity (partition coefficient). At near neutral pH ranges, 3-deoxyanthocyanins 
exist primarily as quinoidal bases (173). Awika (174) reported that some of these 
sorghum 3-deoxyanthocyanin quinoidal bases contained a 2-3 double bond on their C-
ring, which may partly explain the QR inducing capacity observed in this study. 
Methoxyl substitution of 3-deoxyanocyanidins changes their steric configuration and 
enhances their lipophilicity, which may afford them better affinity to specific cell 
membrane binding sites or may favor their migration across the cell membrane. This can 
facilitate the expression of phase II enzymes. 
The 3-deoxyanthocyanidins can be used as dietary supplements or 
chemopreventive agents. A systematic study of the structure-activity relationship of 3-
deoxyanthocyanins is needed to understand how structure affects the activation of 
cellular mechanisms to enhance the expression of phase II enzymes. Other phenolic 
groups present in sorghum also require investigation of their structure-activity 
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relationship. Uda et al. (167) recognized flavonols as the most effective QR inducer 
among flavonoids. Lemon yellow sorghums are a rich source of flavonols (109), and if 
we demonstrate the effectiveness of sorghum flavonols to induce phase II enzymes, it 
will enhance opportunity to utilize sorghum.    
 
Inhibitory Effect of 3-Deoxyanthocyanidin Structure on Human Colon and 
Esophageal Carcinoma Cell Proliferation 
According to Shih et al. (19), the aglycones of sorghum 3-deoxyanthocyanins, 
apigeninidin and luteolinidin, had greater inhibitory potency against human cancer cell 
growth than their 3-hydroxylated analogs, pelargonidin and cyanidin; moreover 
luteolinidin was a stronger inhibitor than apigeninidin. This evidence drove us to 
investigate how the structure of 3-deoxyanthocyanidins affected their antiproliferative 
potency. Genistein, the isoflavone in soybean was used as a positive control in the study.  
To compare the effect of structure on antiproliferative potential of 3-
deoxyanthocyanidins tested, IC50s (μM) of each 3-deoxyanthocyanidin were calculated 
(Table 10). After 48 h incubation, apigeninidin inhibited approximately 60% and 50% of 
HT-29 and OE33 growth, respectively, at 200 μM (Figures 14 and 15), with IC50s from 
81.5-284 μM. 7-Methoxyapigeninidin had stronger inhibitory potential than 
apigeninidin: it inhibited almost 90% of HT-29 growth and 70% of OE33 growth at 200 
μM with IC50s from 40.1-87.9 μM. 5-Methoxyapigeninidin had similar inhibitory 
potency on both HT-29 and OE33 cell lines as its 7-methoxylated analog, with IC50s 
from 48.4-57.7 μM. 5,7-Dimethoxyapigeninidin had the strongest inhibitory potential 
  
85
among apigeninidin derivatives: it almost inhibited 95% of HT-29 and OE33 growth at 
50 μM, IC50s were 8.3-23.4 μM on both cell lines.  
Among luteolinidin and its derivatives, luteolinidin reduced approximately 50% 
and 45% of HT-29 and OE33 growth at 200 μM, respectively (Figures 14 and 15), with 
IC50s from 172-219 μM. 7-Methoxyluteolinidin was a stronger inhibitor than luteolinidin 
on both cell lines, with IC50s 91.4-192 μM. 5,7-Dimethoxyluteolinidin had strongest 
inhibition capacity among luteolinidin derivatives: it inhibited 60-65% of HT-29 and 
OE33 growth at 200 μM and had IC50s from 47.1-105 μM. Genistein, as a control, had 
IC50s from 47.8-111 μM. 
The most obvious structure-activity relationship of 3-deoxyanthocyanidins was 
that methoxylation of the A-ring enhanced antiproliferative capacity. The IC50 trends 
were: di-methoxylated aglycones < mono-methoxylated < non-methoxylated (Figure 
16). The position of methoxyl group on the A-ring did not affect this potential. 
Apigeninidin and its derivatives also generally had lower IC50s than luteolinidin and its 
derivatives, though this was more apparent in the HT-29 cells (Figures 17). 
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Table 10. Concentration (μM) of Sorghum 3-Deoxyanthocyanidins Needed to Inhibit 
50% of HT-29 (colon) and OE33 (lower esophageal) Carcinoma Cell Proliferation (IC50) 
Cells (2000/well) were induced with samples for 48h before proliferation assay. 
Genistein, an isoflavone isolated in soybean, was used as a positive control in this study. 
Values ± sd (μg/mL) reported from three separate experiments. Within apigeninidin and 
luteolinidin and their correspond derivatives, values with different letters within the 
same column were different, and genistein was not included in this Post Hoc test 
(Fisher’s LSD, p<0.05). 
 
 
 
 IC50 (μM) 
 HT-29 OE33 
 MTT PicoGreen MTT PicoGreen 
Apigeninidin 81.5 ± 11.6 c 106 ± 11.8 c 284 ± 11.4 d 276 ± 11.8 c 
7-Methoxyapigeninidin 50.3 ± 7.4 b 40.1 ± 1.9 b 87.9 ± 10.6 c 51.9 ± 0.8 b 
5-Methoxyapigeninidin 53.6 ± 12.6 b 48.4 ± 6.3 b 57.7  ± 0.6 b 55.0 ± 10.6 b 
5,7-Dimethoxyapigeninidin 13.7 ± 0.1 a 8.3 ± 0.7 a 23.4 ± 3.4 a 22.7 ± 0.9 a 
Overall mean 
(apigeninidin and 
derivatives) 
49.7 50.7 113 101 
Luteolinidin 199 ± 11.2 b 188 ± 20.6 c 219 ± 17.2 b 172 ± 20.7 c 
7-Methoxyluteolinidin 91.4 ± 11.5 a 129 ± 6.2 b 192 ± 2.8 b 94.4 ± 7.2 b 
5,7-Dimethoxyluteolinidin 89.6 ± 11.1 a 53.3 ± 0.5 a 105 ± 0.8 a 47.1 ± 0.8 a 
Overall mean 
(luteolinidin and 
derivatives) 
127 123 172 104 
Genistein 97.4 ± 15.3 47.8 ± 2.6 84.7 ± 6.5 111 ± 4.3 
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Figure 14.  Inhibition of HT-29 human colon carcinoma cell proliferation by sorghum 3-deoxyanthocyanidins (baseline to 
0.1% DMSO) measured by MTT (left) and PicoGreen (right) assays. Cells (2000/well) were induced with samples for 48h 
before proliferation assay. Error bars represent standard deviation from triplicates. 
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Figure 15. Inhibition of OE33 human lower esophageal adenocarcinoma cell proliferation by sorghum 3-deoxyanthocyanidins 
(baseline to 0.1% DMSO) measured by MTT (left) and PicoGreen (right) assays. Cells (2000/well) were induced with extracts 
for 48h before proliferation assay. Error bars represent standard deviation from triplicates.
  
89
  To explain this structure-activity relationship of 3-deoxyanthocyanidins, we 
tried to correlate their inhibition capacity with antioxidant capacity (Table 11). The 
ABTS antioxidant capacity of 3-deoxyanthocyanidins had a positive non-linear 
correlation with IC50s measured by MTT assay on both cell lines; while ORAC 
antioxidant capacity had a positive linear correlation with IC50s measured by both MTT 
and PicoGreen assays and on both cell lines. The correlation suggested lower antioxidant 
capacity actually indicated stronger antiproliferative potential. The ORAC values 
seemed to be better predictors because methoxylation reduced ORAC values but 
enhanced antiproliferative potency. Since antioxidant capacity of a compound is highly 
related to its structure and the method used to measure it, antioxidant capacity may not 
have a direct relation with antiproliferative potential. 
 The antiproliferative potential of 3-deoxyanthocyanidins indicated a strong 
structure-activity relationship: methoxylation on the A-ring enhanced inhibitory potency. 
Hydroxylation on the B-ring could reduce inhibitory potency but this relationship may 
be cell line specific. There is little information on the structure-antiproliferation potential 
of 3-deoxyanthocyanidins. However, the inhibitory effect of anthocyanin aglycone 
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Figure 16. Box plot of IC50s (μg/mL) (concentration needed to inhibit 50% of cell 
growth) among non-, mono-, and di-methoxylated 3-deoxyanthocyanidins, (a) IC50s on 
HT-29 proliferation measured by MTT assay (p<0.072); (b) IC50s on HT-29 proliferation 
measured by PicoGreen assay (p<0.014); (c) IC50s on OE33 proliferation measured by 
MTT assay (p<0.002); (d) IC50s on OE33 proliferation measured by PicoGreen assay 
(p<0.001). Boxes with different letters within the same plot were different (p<0.05, 
Fisher’s LSD). Non-, non-methoxylated 3-deoxyanthocyanidins, apigeninidin and 
luteolinidin; mono-, mono-methoxylated 3-deoxyanthocyanidins, 5-
methoxyapigeninidin, 7-methoxyapigeninidin, and 7-methoxyluteolinidin; di-, di-
methoxylated 3-deoxyanthocyanidins, 5,7-dimethoxyapigeninidin and 5,7-
dimethoxyluteolinidin. 
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Figure 17. Box plot of IC50s (μg/mL) (concentration needed to inhibit 50% of cell 
growth) between apigeninidin derivatives and luteolinidin derivatives, (a) IC50s on HT-
29 proliferation measured by MTT assay (p<0.014); (b) IC50s on HT-29 proliferation 
measured by PicoGreen assay (p<0.042); (c) IC50s on OE33 proliferation measured by 
MTT assay (p<0.473); (d) IC50s on OE33 proliferation measured by PicoGreen assay 
(p<0.828). Api family, apigeninidin, 5-methoxyapigeninidin, 7-methoxyapigeninidin, 
and 5,7-dimethoxyapigeninidin; lut family, luteolinidin, 7-methoxyluteolinidin, 5,7-
dimethoxyluteolinidin. 
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Table 11. Correlation between IC50s and Antioxidant Properties of  
 3-Deoxyanthocyanidin Standards 
 
Correlation coefficient 
IC50 (μM) 
HT-29 OE33 
MTT PicoGreen MTT PicoGreen
Pearson’s 
Correlation 
ABTS 0.499 0.377 0.461 0.273 
ORAC 0.732** 0.772** 0.887** 0.804** 
Spearman’s 
rho 
ABTS 0.747** 0.551 0.660* 0.239 
ORAC 0.687* 0.711** 0.799** 0.673* 
     *correlation is significant at the 0.05 level (2-tailed). 
     **correlation is significant at the 0.01 level (2-tailed). 
 
structure on carcinogenesis is mostly affected by substitution on the B-ring: number of 
hydroxyl/methoxyl group on the B-ring of anthocyanin aglycone positively correlated 
with stronger cancer cell growth inhibitory action (175, 176). Hydroxylation also 
enhanced apoptosis inducing (177) and antiproliferative potential (178) of flavones. Our 
findings were in accordance with the literature on methoxyl substitution but did not 
match the literature on hydroxyl substitution. Other reports showed methoxyl 
substitution and substitution of other lipophilic groups enhanced antiproliferative 
potency of phenolic compounds (179, 180). Greater lipophilicity allows easier 
penetration into the cell (181). Hydroxylation of luteolinidin and its derivatives reduce 
their lipophilicity compared to apigeninidin and its derivatives hence luteolinidin and its 
derivatives may not easily get into cells.  
For future study, a more complete structure-activity relationship of 3-
deoxyanthocyanins is desired. Research on chemopreventive effect of hydroxylation and 
methoxylation at different positions on 3-deoxyanthocyanin aglycones is needed. 
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Because glycosylation of flavonoids reduced their inhibitory activity against human 
cancer cell lines (178), it is highly recommended to study the effect of glycosylation, the 
most common substitution pattern in sorghum 3-deoxyanthocyanins, on their 
chemopreventive potentials. Additionally, Marko and others (176) indicated that the 
effect of B-ring substitution of anthocyanidins might vary depending on different assays 
used. So the research on chemopreventive potential of 3-deoxyanthocyanins should 
involve different mechanisms (i.e. apoptosis induction, cell cycle arrest, and cell 
membrane sites binding) on various cell lines. Other phenolic compounds in sorghum, 
such as flavones and flavonols deserve further study on their chemopreventive potential. 
Daskiewicz and co-workers (182) reported that among 42 flavonoids with different 
substitution at various positions examined for human cancer cell antiproliferation 
capacity, flavones and flavonols possessed greater antiproliferative activity than 
chalcones and flavanones. The study on all major groups of sorghum phenols will be of 
great benefit to utilize sorghum in health related industries. 
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CHAPTER VII 
SUMMARY 
 
We observed a wide rage of phenolic profiles among different varieties of 
sorghum. Tannin sorghums contained higher total phenols (p<0.001), ABTS (p<0.001) 
and ORAC (p<0.006) antioxidant capacity than non-tannin sorghums, similar to findings 
of Awika et al. (95) and Dykes (109). Among non-tannin sorghum grains, 3-
deoxyanthocyanin content had a significant correlation with total phenol content 
(p<0.01), ABTS (p<0.01), and ORAC (p<0.05) antioxidant capacity. The crude 70% 
actone extracts of sorghum grains had similar phenolic profiles as their grains. However, 
the ORAC antioxidant capacity of the extracts did not differ between tannin and non-
tannin extracts (p<0.194) hence tannin content of the extracts did not correlate with their 
ORAC values. Some non-tannin sorghum extracts, such as 98BRON155, 99LGWO50, 
Tx2911, had high ORAC values as tannin sorghum extracts. The extraction process may 
concentrate some groups of phenols in these varieties (i.e. flavanones, flavones, flavan-
4-ols (109)) that exhibited high ORAC values among those sorghums.  
The NAD(P)H: quinone reductase (QR) inducing capacity of selected sorghum 
varieties was different between tannin and non-tannin sorghums. Tannin sorghums did 
not show QR inducing potential. Among non-tannin sorghums, black sorghum (Tx430) 
doubled QR activity at 25 μg/mL, and increased the activity 2.7-fold at 100 μg/mL. Two 
red varieties (Mizzou and I CSV III) increased QR activity by 50-60% at 200 μg/mL 
while the white variety (KARI-Mtama) doubled QR activity at 400 μg/mL. The QR 
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inducing capacity did not correlate with the phenol content or antioxidant capacity of 
selected varieties. This indicated that the QR inducing potential may be related to 
structure of active phenols present in sorghums. Further investigation into how phenol 
composition affects phase II enzyme inducing capacity is needed. Future study could 
focus on 1) the phase II enzyme inducing potential of fractionated sorghum extracts 
containing isolated phenols (i.e. 3-deoxyanthocyanins, flavones, flavanones), 2) the 
specific cellular mechanism of the inducing potential (i.e. measure expression of genes 
that upregulate phase II enzymes), and 3) other enzymes in phase II family. 
All the crude sorghum extracts tested had a relatively strong antiproliferative 
potential against human gastrointestinal cancer cell proliferation, though inhibitory 
potential was different between tannin and non-tannin sorghum varieties. Tannin 
sorghums generally had a stronger inhibitory effect on cancer cell growth than non-
tannin sorghums (IC50s 49.7-131 vs. 141-883 μg/mL). Among non-tannin sorghums, 
black sorghum (Tx430) showed the strongest antiproliferative potential followed by red 
(Mizzou), then white (KARI-Mtama and Mizzou White) varieties. This inhibitory effect 
correlated with total phenol content and antioxidant capacity of the extracts. This 
indicated that the antioxidant capacity may be indicators of inhibitory potential. Some 
varieties of strong antioxidant non-tannin sorghum were not tested in our study, i.e. 
98BRON155, 99LGWO50, and Tx2911, hence it will be beneficial if we can use them to 
confirm this theory. Future study could 1) determine the antiproliferative potential of 
different phenolic fractions of sorghum extracts, 2) target specific mechanisms of the 
antiproliferative effect, such as induction of apoptosis, arresting cell cycles, or 
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preventing DNA damage, 3) determine the antiproliferative potential of sorghum using 
additional gastrointestinal and other types of cancer cells, to have a better understanding 
of the chemopreventive properties of sorghum. 
 Among the 3-deoxyanthocyanidins tested, the activity trends for both QR 
inducing and antiproliferation were similar: methoxylation improved the potency of 
apigeninidin and luteolinidin. On the other hand, apigeninidin and its methoxylated 
derivatives generally have stronger antiproliferative potential than luteolinidin and 
derivatives. For future study, 1) more substitution pattern, i.e. glycosylation, 
hydroxylation, multi-methoxylation/hydroxylation, of 3-deoxyanthocyanidins need to be 
studied for a complete structure-activity relationship, 2) specific cellular 
chemopreventive mechanisms, such as affinity to bind specific cell membrance sites, 
permeability across the cell membrane, induction of apoptosis, cell cycle arrest, and 
repair of damaged DNA need to be studied, 3) other groups of phenols present in 
sorghum (i.e. flavones, flavanones, flavol-4-ols) need to be studied for their 
chemopreventive properties. 
 On the whole, we observed a relatively strong chemopreventive potential of 
sorghums with different phenolic compositions. Future studies should not only aim at the 
aforementioned chemopreventive aspects, but also focus on the effect of food 
processing, storage, and use of additives on the chemopreventive potentials of sorghum 
phenols. Also, determining the chemopreventive roles of sorghum on healthy population 
is desirable. This information can be used to promote the utilization of sorghum grains, 
crude extracts, and isolated compounds. Applications could target direct food use, use as 
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functional food ingredients, and dietary supplements. The information would also be 
useful to breeding programs to selectively breed sorghum varieties for specific health 
applications.  
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